Assembly requirements of PU.1–Pip (IRF‐4) activator complexes: inhibiting function in vivo using fused dimers
Open accessAbstract
Gene expression in higher eukaryotes appears to be regulated by specific combinations of transcription factors binding to regulatory sequences. The Ets factor PU.1 and the IRF protein Pip (IRF-4) represent a pair of interacting transcription factors implicated in regulating B cell-specific gene expression. Pip is recruited to its binding site on DNA by phosphorylated PU.1. PU.1-Pip interaction is shown to be template directed and involves two distinct protein-protein interaction surfaces: (i) the ets and IRF DNA-binding domains; and (ii) the phosphorylated PEST region of PU.1 and a lysine-requiring putative alpha-helix in Pip. Thus, a coordinated set of protein-protein and protein-DNA contacts are essential for PU.1-Pip ternary complex assembly. To analyze the function of these factors in vivo, we engineered chimeric repressors containing the ets and IRF DNA-binding domains connected by a flexible POU domain linker. When stably expressed, the wild-type fused dimer strongly repressed the expression of a rearranged immunoglobulin lambda gene, thereby establishing the functional importance of PU.1-Pip complexes in B cell gene expression. Comparative analysis of the wild-type dimer with a series of mutant dimers distinguished a gene regulated by PU.1 and Pip from one regulated by PU.1 alone. This strategy should prove generally useful in analyzing the function of interacting transcription factors in vivo, and for identifying novel genes regulated by such complexes.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
22 of 49 cited sources checked · 11 supported · 0 flagged · accuracy not yet measured
- Premisecitation
Ectopic co-expression of PU.1 and Pip synergistically activates a reporter containing multiple copies of the IgL lambda composite element E lambda 2-4.
“When co-expressed ectopically, PU.1 and Pip synergistically activate transcription of a reporter gene containing multiple copies of the composite element from the IgL λ enhancer, E λ2-4 (Eisenbeis et al., 1995).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Eisenbeis et al., 1995 source
- Premisecitation
A C-terminal regulatory domain in Pip is required for ternary complex assembly.
“A C-terminal regulatory domain within Pip itself is also required for ternary complex assembly (Brass et al., 1996).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Brass et al., 1996 source
The deletion analysis reports that Pip amino acids 410–439 are necessary for high-affinity ternary complex formation with PU.1. However, mutants lacking that segment still formed weak ternary complexes, so the paper does not show that the C-terminal domain is required for assembly altogether. The relevant passages are in the section on Pip repression of IFN-inducible transcription; page numbers are unavailable in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Pip's regulatory domain autoinhibits Pip DNA binding in the absence of PU.1.
“In addition, this regulatory domain autoinhibits binding of Pip to DNA in the absence of PU.1.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Brass et al., 1996 source
- Premisecitation
A putative alpha-helical region in Pip's C-terminus (amino acids 399-413) was previously suggested to be important for ternary complex formation with PU.1.
“Previously, using deletion analysis and secondary structure predictions, we suggested that a putative α-helical region (amino acids 399-413) in Pip's C-terminus is important for ternary complex formation with PU.1 (Figure 1A and B; Brass et al., 1996).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Brass et al., 1996 source
- Premisecitation
PU.1 and Pip are major components of the ternary complex formed with nuclear extract from J558L cells.
“PU.1 and Pip represent the major components of the ternary complex formed with nuclear extract from these cells”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Brass et al., 1996 source
- Interpretationcitation
On lower-affinity sites, the linker's chelating effect may lower entropic cost, allowing PipPU to bind as efficiently as wild-type proteins.
“On lower affinity sites, however, the chelating effect provided by the linker may lower the overall entropic cost associated with binding, allowing PipPU to bind as efficiently as the wildtype proteins”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Klemm and Pabo, 1996 source
The “Contribution of the linker to cooperative binding” section (page unavailable) says the linker produces a chelate effect and reduces the entropic cost of complex formation. The paper studies Oct-1 POU-domain binding; it does not establish that PipPU binds lower-affinity sites as efficiently as wild-type proteins. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Interpretationcitation
Other uncharacterized helices in Pip's region 150-340 may pack with helix 395-413 to form a fold competent for PU.1 association.
“it appears that other, as yet uncharacterized helices within this region may pack together with Pip's helix amino acids 395-413 to form a tertiary fold which is competent for PU.1 association.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Brass et al., 1996 source
In the deletion-analysis passage (page not available), removing Pip residues 150–340 weakened ternary complex formation with PU.1; the authors suggest that region may position the carboxy-terminal domain or contain another required region. In “Structural basis for PU.1-dependent DNA-binding of Pip” (page not available), they propose a role for a putative helix near residues 399–413. Our copy does not say that uncharacterized helices in residues 150–340 pack with it to form a tertiary fold. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Interpretationcitation
J chain inhibition is presumably due to displacement of endogenous PU.1 from an isolated Ets site in the J chain promoter.
“This is presumably due to displacement of endogenous PU.1 from an isolated Ets site in the J chain promoter”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Shin and Koshland, 1993 source
- Interpretationcitation
This is consistent with increased Pip expression in plasma cell lines such as J558L.
“This is consistent with increased expression of Pip in plasma cell lines such as J558L”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Brass et al., 1996 source
- Premisecitation
Each enhancer contains an essential composite site (λB) bound by PU.1 and Pip.
“Each enhancer contains an essential composite site (λB) bound by PU.1 and Pip”
Quote in the paperSubstantial claim1 of 3 sources checked- cites Hagman et al., 1990 source
The Abstract identifies two lambda enhancers, and “Cloning of a second enhancer and comparison with” discusses conserved sequence motifs. Neither passage identifies an essential λB composite site or reports binding by PU.1 and Pip; searches for those terms found no supporting passage in our copy. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites Rudin and Storb 1992
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Eisenbeis et al., 1993 source
- Findingown data
Full-length Pip's affinity for the PU.1-DNA complex is more than 800-fold greater than that of the Pip DBD (2.6 nM versus 2.1 micromolar).
“However, the affinity of full-length Pip for the PU.1-DNA complex is Ͼ800-fold greater than that observed for the Pip DBD (2.6 nM versus 2.1 µM).”
Quote in the paperSubstantial claim - Findingown data
The isolated Pip DBD has intrinsic weak DNA affinity with Kd about 96 micromolar.
“Unlike full-length Pip, the isolated Pip DBD possessed intrinsic, albeit weak, DNA affinity (K d ~96 µM, compare Figures 3B and 4A), consistent with removal of the autoinhibitory domain.”
Quote in the paperSubstantial claim - Findingown data
PU.1-Pip interaction involves the phosphorylated PEST region of PU.1 and a lysine-requiring putative alpha-helix in Pip.
“PU.1-Pip interaction is shown to be template directed and involves two distinct protein-protein interaction surfaces: (i) the ets and IRF DNA-binding domains; and (ii) the phosphorylated PEST region of PU.1 and a lysine-requiring putative α-helix in Pip.”
Quote in the paperSubstantial claim - Findingown data
PU.1-Pip interaction involves the ets and IRF DNA-binding domains.
“PU.1-Pip interaction is shown to be template directed and involves two distinct protein-protein interaction surfaces: (i) the ets and IRF DNA-binding domains; and (ii) the phosphorylated PEST region of PU.1 and a lysine-requiring putative α-helix in Pip.”
Quote in the paperSubstantial claim - Findingown data
Glutaraldehyde cross-linking detected a Pip-containing adduct of about 80-85 kDa, consistent with a Pip-PU.1 heterodimer.
“A glutaraldehyde-dependent adduct containing Pip was detected, with a molecular mass of ~80-85 kDa, in excellent agreement with the predicted size of a crosslinked species comprising a heterodimer of Pip and PU.1 983 (Figure 5B, compare lanes 1 and 2).”
Quote in the paperSubstantial claim - Findingown data
Chimeric proteins containing two or three copies of the linker bound to the lambdaB site with highest affinity.
“Chimeric proteins containing either two or three copies of the linker bound to the λB site with highest affinity.”
Quote in the paperSubstantial claim - Findingown data
Alanine substitution of Pip amino acids 397-400 (PipAS397) impaired ternary complex formation to about 1% of wild-type binding.
“The alanine substitution of amino acids 397-400 (PipAS397) and 401-404 (PipAS401) within the predicted helix impaired ternary complex formation, resulting in ~1 or 26% binding, respectively, as compared with wild-type Pip (Figure 1D, compare lane 3 with lanes 6 and 7).”
Quote in the paperSubstantial claim - Findingown data
Substitution of arginine for lysine at position 399 retained 40% of wild-type binding.
“A substantial retention of wild-type binding (40%) was seen after substitution of an arginine for lysine at that position (Figure 1E, compare lanes 9 and 3).”
Quote in the paperSubstantial claim - Findingown data
Pip's DNA-binding activity is completely dependent on PU.1 at all protein concentrations tested.
“We observed that the DNA-binding activity of Pip was completely dependent on the presence of PU.1 at all protein concentrations tested (Figure 3B and C).”
Quote in the paperSubstantial claim - Findingown data
Formation of the PU.1-Pip protein adduct depends on lambdaB DNA containing intact PU.1- and Pip-binding sites.
“Formation of the PU.1-Pip protein adduct was dependent on: (i) phosphorylation of Ser148 in PU.1; (ii) Lys399 in Pip's interaction helix; and (iii) λB DNA containing intact PU.1-and Pip-binding sites (Figure 5B, lanes 3-8, probes designated B1 and B2 contain severe mutations in either the PU.1-or Pip-binding sites; detailed in Figure 6B).”
Quote in the paperSubstantial claim - Findingown data
Alanine substitution of Pip amino acids 389-392 (PipAS389) impaired ternary complex formation to 17% of wild-type binding.
“Furthermore, the region immediately preceding the helix, amino acids 389-392 (PipAS389), was also important for complex formation (17% of wild-type Pip binding; Figure 1D, lanes 3 and 4).”
Quote in the paperSubstantial claim - Findingown data
IRF-1 DBD bound the lambdaB site as both a monomer and a dimer.
“(ii) the IRF-1 DBD bound the λB site as both a monomer and a dimer;”
Quote in the paperSubstantial claim - Findingown data
The increasing ability of PipAS401, PipAS405, and PipAS409 to stimulate transcription correlated with increasing ternary complex formation.
“The increasing ability of the PipAS401, 405 and 409 proteins to stimulate transcription correlated with increasing propensity for ternary complex formation (Figure 1D; Table I).”
Quote in the paperSubstantial claim - Findingown data
PipAS397 was least effective among the alanine substitution mutants in stimulating transcription.
“Consistent with the biochemical analysis, PipAS397 was least effective in stimulating transcription (Table I).”
Quote in the paperSubstantial claim - Findingown data
Alanine substitution of Pip amino acids 401-404 (PipAS401) impaired ternary complex formation to 26% of wild-type binding.
“The alanine substitution of amino acids 397-400 (PipAS397) and 401-404 (PipAS401) within the predicted helix impaired ternary complex formation, resulting in ~1 or 26% binding, respectively, as compared with wild-type Pip (Figure 1D, compare lane 3 with lanes 6 and 7).”
Quote in the paperSubstantial claim - Findingown data
The isolated ets domain of PU.1 (amino acids 160-272) recruited Pip DBD to lambdaB comparably to PU.1 containing the PEST region (amino acids 119-272).
“Furthermore, similar experiments revealed that the isolated ets domain of PU.1 (amino acids 160-272) recruited the Pip DBD to the λB site comparably with the PU.1 protein containing the PEST region (amino acids 119-272, Figure 4C).”
Quote in the paperSubstantial claim - Findingown data
The cross-linked protein adduct also contained PU.1.
“Western blotting using anti-PU.1 antisera showed that this protein adduct also contained PU.1 (data not shown).”
Quote in the paperSubstantial claim - Findingown data
Formation of the PU.1-Pip protein adduct depends on Lys399 in Pip's interaction helix.
“Formation of the PU.1-Pip protein adduct was dependent on: (i) phosphorylation of Ser148 in PU.1; (ii) Lys399 in Pip's interaction helix; and (iii) λB DNA containing intact PU.1-and Pip-binding sites (Figure 5B, lanes 3-8, probes designated B1 and B2 contain severe mutations in either the PU.1-or Pip-binding sites; detailed in Figure 6B).”
Quote in the paperSubstantial claim - Findingown data
PU.1 and full-length Pip synergistically activated transcription 17-fold in NIH 3T3 cells with the B4-TKCAT reporter.
“Consistent with previous data, PU.1 and Pip (FLPip) synergistically activated transcription (17-fold).”
Quote in the paperSubstantial claim - Findingown data
No changes in the rate or pattern of proteolysis were detected when Pip was recruited by PU.1 on lambdaB DNA.
“No changes in the rate or pattern of proteolysis were detected when Pip was recruited by PU.1 on λB DNA (Figure 3A, compare lanes 1-6 with lanes 7-12).”
Quote in the paperSubstantial claim - Findingown data
Formation of the PU.1-Pip protein adduct depends on phosphorylation of Ser148 in PU.1.
“Formation of the PU.1-Pip protein adduct was dependent on: (i) phosphorylation of Ser148 in PU.1; (ii) Lys399 in Pip's interaction helix; and (iii) λB DNA containing intact PU.1-and Pip-binding sites (Figure 5B, lanes 3-8, probes designated B1 and B2 contain severe mutations in either the PU.1-or Pip-binding sites; detailed in Figure 6B).”
Quote in the paperSubstantial claim - Findingown data
IRF-1 DBD has higher DNA affinity than the Pip DBD.
“These data demonstrated: (i) the high DNA affinity of IRF-1's DBD compared with that of the Pip DBD (compare Figure 4D with A, taking note of protein concentrations);”
Quote in the paperSubstantial claim - Findingown data
PU.1-Pip interaction is template directed.
“PU.1-Pip interaction is shown to be template directed and involves two distinct protein-protein interaction surfaces: (i) the ets and IRF DNA-binding domains; and (ii) the phosphorylated PEST region of PU.1 and a lysine-requiring putative α-helix in Pip.”
Quote in the paperSubstantial claim - Findingown data
PipE406P severely reduced interaction with PU.1 to 2% of wild-type levels.
“PipE406P showed severely reduced interaction with PU.1 (2% of wild-type levels; Figure 1E, compare lane 10 with lane 3).”
Quote in the paperSubstantial claim - Findingown data
Alanine substitution mutagenesis of residues 389-420 showed that amino acids 401-408 are specifically required for autoinhibition.
“Alanine substitution mutagenesis of residues 389-420 showed that amino acids 401-408 were specifically required for autoinhibition (Figure 2A, compare lane 2 with lanes 7 and 8).”
Quote in the paperSubstantial claim - Findingown data
Increasing concentrations of IRF-1 DBD displaced either PU.1 or PU.1 DBD from the lambdaB site.
“(iii) increasing concentrations of the IRF-1 DBD displaced either PU.1 or PU.1 DBD from the λB site.”
Quote in the paperSubstantial claim - Findingown data
Mutation of E406 to proline generated a protein that bound DNA independently 32-fold above background.
“Mutation of E406 to proline also generated a protein which bound DNA independently (32-fold above background), suggesting that overall helix integrity is necessary for both autoinhibition and ternary complex formation (Figure 2A, compare lanes 2 and 12).”
Quote in the paperSubstantial claim - Findingown data
Pip binding depends on pSer148, as shown by the phosphorylation-defective PU.1S148A mutant.
“In addition, gel shift assays using the phosphorylation-defective PU.1 mutant, PU.1S148A, showed that the binding of Pip was dependent on the presence of pSer148 (data not shown).”
Quote in the paperSubstantial claim - Findingown data
The interaction between isolated Pip DBD and PU.1 does not depend on Ser148 phosphorylation.
“We note that the interaction between the isolated DBD of Pip and PU.1 is not dependent on phosphorylation of Ser148 since the phosphorylation-deficient PU.1S148A interacted with the Pip DBD equivalently to PU.1 (data not shown).”
Quote in the paperNot a substantial claim - Findingown data
Substitution of Lys399 by alanine reduced ternary complex assembly to 8% of wild-type.
“This experiment showed that Lys399 was important for ternary complex formation, as its substitution by alanine resulted in 8% of wild-type complex assembly (Figure 1E, lane 7).”
Quote in the paperSubstantial claim - Findingown data
The equilibrium dissociation constant of Pip in the presence of PU.1 is about 2.6 nM.
“The data from gel shift assays allowed us to calculate the equilibrium dissociation constant (K d ) of Pip in the presence of PU.1 to be ~2.6 nM (Figure 3D).”
Quote in the paperSubstantial claim - Findingown data
Pip DBD bound the lambdaB template with higher affinity in the presence of PU.1, Kd about 2.1 micromolar.
“Pip DBD bound the λB template with higher affinity in the presence of PU.1, K d ~2.1 µM (Figure 4A and B).”
Quote in the paperSubstantial claim - Findingown data
Mutation of Glu406 to alanine had no effect on ternary complex formation.
“Importantly, mutation of this Glu406 to an alanine had no effect on ternary complex formation, indicating that the nature of the side chain was not critical (data not shown).”
Quote in the paperSubstantial claim - Findingown data
Alanine substitutions of Arg398 and Leu400 diminished complexation to 45% or 31% of wild-type binding.
“Alanine subsitutions of Arg398 and Leu400 also diminished complexation (45 or 31% of wild-type binding levels; Figure 1E, compare lane 3 with lanes 6 and 8).”
Quote in the paperSubstantial claim - Findingown data
Comparative analysis of the wild-type dimer with mutant dimers distinguished a gene regulated by PU.1 and Pip from one regulated by PU.1 alone.
“Comparative analysis of the wild-type dimer with a series of mutant dimers distinguished a gene regulated by PU.1 and Pip from one regulated by PU.1 alone.”
Quote in the paperSubstantial claim - Findingown data
When stably expressed, the wild-type fused dimer strongly repressed expression of a rearranged immunoglobulin lambda gene.
“When stably expressed, the wild-type fused dimer strongly repressed the expression of a rearranged immunoglobulin λ gene, thereby establishing the functional importance of PU.1-Pip complexes in B cell gene expression.”
Quote in the paperSubstantial claim - Findingown data
On the CD20 element, PipPU bound with affinity comparable to PU.1 and Pip.
“On the CD20 element, PipPU bound with comparable affinity to PU.1 and Pip”
Quote in the paperSubstantial claim - Findingown data
Substitution of Lys399 by arginine partially restored complex formation, indicating a positively charged residue at this site is important.
“Substitution of Lys399 by arginine partially restored complex formation, showing that a positively charged residue at this site is an important structural component of the complex.”
Quote in the paperSubstantial claim - Findingown data
The double mutant fused dimer did not detectably interact with composite sites.
“the double mutant (DM) fused dimer did not interact detectably with the composite sites”
Quote in the paperSubstantial claim - Findingcitation
PU.1 bound the CD20 composite site with lower affinity than the λB site.
“PU.1 bound with lower affinity to the CD20 site as compared with λB”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Himmelman et al., 1997
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingown data
On the λB site, PU.1 and Pip bound about fourfold more strongly than the PipPU chimera.
“the binding of PU.1 and Pip to λB was greater than that of the chimera (4-fold)”
Quote in the paperSubstantial claim - Findingown data
The wild-type chimera PipPU repressed endogenous IgL λ gene expression 17-fold.
“the wild-type chimera (PipPU) potently repressed endogenous IgL λ gene expression (17-fold).”
Quote in the paperSubstantial claim - Findingown data
Pipmut and PUmut inhibited IgL λ expression less effectively, with 5.5-fold and 1.8-fold repression, respectively.
“the Pipmut or PUmut mutant chimeras inhibited less effectively (5.5-and 1.8-fold repression, respectively).”
Quote in the paperSubstantial claim - Findingown data
The J chain gene was repressed equivalently by wild-type and Pipmut repressors.
“the J chain gene was repressed equivalently by the wild-type and Pipmut repressors.”
Quote in the paperSubstantial claim - Findingown data
Binding of PUmut to the composite element depended strictly on the Pip binding site.
“the binding of PUmut to the composite element was strictly dependent on the Pip binding site”
Quote in the paperSubstantial claim - Findingown data
The Eλ2-4 element stimulated transcription 12-fold.
“the presence of E λ2-4 stimulated transcription 12-fold.”
Quote in the paperNot a substantial claim - Findingown data
Alanine substitution showed Arg398, Lys399 and Leu400 in the predicted helix are critical for PU.1-Pip interaction in vitro and in vivo.
“The alanine substitution study demonstrated that Arg398, Lys399 and Leu400, located within this predicted helix and conserved between Pip and ICSBP, are critical for PU.1-Pip interaction in vitro and in vivo”
Quote in the paperSubstantial claim - Findingown data
The PipPU fused dimer bound the wild-type CD20 site with eightfold higher affinity than the C2 mutant site, which has a mutation in the Pip-binding site.
“the PipPU fused dimer bound the wild-type CD20 site with an 8-fold higher affinity than the C2 mutant site”
Quote in the paperSubstantial claim- Rests on an assumption: The CD20 composite element contains a lower-affinity PU.1-binding site (AAAGAA).
- Findingown data
PipPU was somewhat more effective at blocking reporter gene activity than PUmut or Pipmut.
“The PipPU protein was somewhat more effective at blocking reporter gene activity as compared with the PUmut or Pipmut proteins.”
Quote in the paperNot a substantial claim - Findingown data
The PU.1 mutant bound λB and CD20 sites with affinity similar to the wild-type fused dimer.
“the PU.1 mutant (PUmut) bound the λB and CD20 sites with affinity similar to the wild-type fused dimer”
Quote in the paperSubstantial claim - Findingown data
In gel shift assays with the λB site, PipPU preferred the composite element over a probe containing only a PU.1 site by about threefold.
“PipPU preferred the composite element to one containing only a PU.1 site by a factor of 3”
Quote in the paperSubstantial claim - Findingown data
The half-life of the PU.1-Pip ternary complex was nearly identical to that of PU.1 alone.
“the half-life of the PU.1-Pip ternary complex was nearly identical to that of PU.1 alone”
Quote in the paperSubstantial claim - Findingown data
PUmut had DNA specificity different from PipPU.
“Although the DNA affinity of PUmut was comparable with that of PipPU, its DNA specificity was quite different.”
Quote in the paperSubstantial claim - Findingown data
The wild-type PipPU chimera inhibited J chain gene transcription 3.5-fold.
“Transcription of the J chain gene was inhibited 3.5-fold by the wild-type PipPU chimera.”
Quote in the paperSubstantial claim - Findingown data
Interdependent protein-protein and protein-DNA contacts regulate PU.1-Pip ternary complex assembly.
“Here we undertake a series of biochemical studies to elucidate this mechanism, and find that interdependent protein-protein and protein-DNA contacts regulate PU.1-Pip ternary complex assembly.”
Quote in the paperSubstantial claim - Findingown data
The PUmut chimera did not inhibit J chain gene transcription.
“J chain gene transcription was not inhibited by the PUmut chimera.”
Quote in the paperSubstantial claim - Findingown data
We detected an additional, much weaker cooperative interaction between Pip's DBD and PU.1's DBD.
“We also detected an additional, albeit much weaker, cooperative interaction between Pip's DBD and PU.1's DBD.”
Quote in the paperSubstantial claim - Findingown data
Glutaraldehyde cross-linking showed PU.1-Pip adducts are detectable only in the presence of cognate DNA, indicating template-directed interaction.
“glutaraldehyde cross-linking demonstrated that the protein-protein interaction is template directed, because PU.1-Pip cross-linked adducts are detectable only in the presence of cognate DNA.”
Quote in the paperSubstantial claim - Findingown data
The DBD-DBD interaction was specific because IRF-1 bound competitively with PU.1 on the λB site.
“Subsequent assays suggested that this interaction was specific, because a Pip homolog, IRF-1, bound competitively with PU.1 on the λB site.”
Quote in the paperNot a substantial claim - Findingown data
Elimination of Pip's regulatory domain results in an 800-fold drop in affinity of Pip for the PU.1-DNA complex.
“elimination of the regulatory domain results in an 800-fold drop in the affinity of Pip for the PU.1-DNA complex.”
Quote in the paperSubstantial claim - Findingown data
Mutations in a hydrophobic patch at the C-terminus of the helix (aa 401-408) alleviated autoinhibition.
“Mutations in a predominantly hydrophobic patch at the C-terminus of the helix (amino acids 401-408) resulted in alleviation of autoinhibition.”
Quote in the paperSubstantial claim - Findingown data
Proteins containing the POU domain linker were stable in transient and stable expression systems.
“proteins containing this linker were found to be stable in both transient and stable expression systems”
Quote in the paperSubstantial claim - Findingown data
Fusion of the two DBDs greatly enhanced DNA-binding stability compared with wild-type PU.1 or PU.1-Pip.
“kinetic analysis demonstrated that fusion of the two DBDs greatly enhanced DNA-binding stability as compared with wildtype PU.1 or PU.1-Pip”
Quote in the paperSubstantial claim - Findingnone given
Prototypical IRF family members IRF-1 and IRF-2 bind DNA with high affinity.
“the prototypical members of the IRF family, IRF-1 and IRF-2, bind to DNA with high affinity.”
Quote in the paperSubstantial claim - Findingown data
Two chymotrypsin cleavage sites in Pip were mapped to Tyr169 and Trp178 in the authors' assays.
“The asterisk denotes two chymotrypsin cleavage sites mapped in our assays (Tyr169 and Trp178).”
Quote in the paperNot a substantial claim - Findingown data
When stably expressed, PipPU repressed IgL λ more efficiently than mutant chimeras.
“When stably expressed, PipPU repressed an EICE-containing gene, IgL λ, more efficiently than the mutant chimeras”
Quote in the paperSubstantial claim - Findingown data
Cross-linking between PU.1 and Pip depends on the DNA template.
“PU.1 and Pip cross-linking is DNA template dependent.”
Quote in the paperSubstantial claim - Findingown data
The PUmut dimer formed a less stable protein-DNA complex (half-life 6 min) than complexes with PipPU or Pipmut (half-life 60 min).
“The PUmut dimer formed a protein-DNA complex that was considerably less stable (half-life ϭ 6 min) as compared with those complexes containing PipPU or Pipmut (half-life ϭ 60 min).”
Quote in the paperSubstantial claim - Findingown data
When stably expressed, the wild-type PipPU chimera strongly inhibits endogenous immunoglobulin λ gene expression.
“The wild-type PipPU chimera potently inhibits endogenous immunoglobulin λ gene expression when stably expressed.”
Quote in the paperSubstantial claim - Findingown data
The structural determinants that mediate autoinhibition of Pip DNA binding overlap with those needed for ternary complex formation.
“Structural determinants required for autoinhibition of Pip DNA binding overlap with, but can be uncoupled from, those required for ternary complex formation.”
Quote in the paperSubstantial claim - Findingreasoning
In transient assays, Pipmut and PUmut repressed transcription similarly to wild-type chimera.
“in transient assays, the Pipmut and PUmut chimeras repressed transcription similarly to the wild-type chimera.”
Quote in the paperNot a substantial claim - Findingcitation
J chain gene transcription was inhibited by wild-type PipPU chimera.
“Transcription of the J chain gene was also inhibited by the wild-type PipPU chimera.”
Quote in the paperSubstantial claim - Findingown data
PU.1 binds cooperatively with the DNA-binding domain of Pip.
“PU.1 binds cooperatively with the DBD of Pip but competitively with the related DBD of IRF-1.”
Quote in the paperSubstantial claim - Findingown data
Both wild-type and mutant PipPU chimeras repress λ enhancer activity in transient transfection assays.
“Both wild-type and mutant PipPU chimeras repress λ enhancer function in transient transfection assays.”
Quote in the paperSubstantial claim - Findingown data
Several residues within Pip's interaction helix are required for the formation of a ternary complex with PU.1 in vitro.
“Multiple residues in Pip's interaction helix are important for ternary complex formation with PU.1 in vitro and transcriptional synergy in vivo.”
Quote in the paperSubstantial claim - Findingown data
Both DBDs contribute to the higher combined affinity and selectivity of PipPU compared with either mutant.
“Our gel shift studies revealed that both DBDs contribute to the higher combined affinity and selectivity of the PipPU chimera as compared with either of the mutants.”
Quote in the paperSubstantial claim - Findingown data
The structural determinants that mediate autoinhibition of Pip DNA binding can be separated from those needed for ternary complex formation.
“Structural determinants required for autoinhibition of Pip DNA binding overlap with, but can be uncoupled from, those required for ternary complex formation.”
Quote in the paperSubstantial claim - Findingown data
J chain gene was repressed equivalently by wild-type and Pipmut repressors.
“the J chain gene was repressed equivalently by the wild-type and Pipmut repressors.”
Quote in the paperSubstantial claim - Findingown data
PU.1 binds competitively with the related DNA-binding domain of IRF-1.
“PU.1 binds cooperatively with the DBD of Pip but competitively with the related DBD of IRF-1.”
Quote in the paperSubstantial claim - Findingown data
Several residues within Pip's interaction helix are required for transcriptional synergy in vivo.
“Multiple residues in Pip's interaction helix are important for ternary complex formation with PU.1 in vitro and transcriptional synergy in vivo.”
Quote in the paperSubstantial claim - Findingown data
In stably expressing cells, maximal repression of endogenous IgL λ gene depended on both wild-type Pip and PU.1 DBDs.
“upon testing the effects of these proteins on endogenous IgL λ gene transcription in stably expressing cells, significant differences in their function were found, with maximal repression depending on the presence of both wild-type Pip and PU.1 DBDs.”
Quote in the paperSubstantial claim - Premisecitation
PU.1 and Pip form complexes in B cells on composite elements in immunoglobulin light chain gene enhancers.
“The lymphoid-restricted interferon regulatory factor, Pip (IRF-4), and the hematopoietic-specific Ets protein, PU.1, form complexes in B cells on composite elements present in immunoglobulin light chain (IgL) gene enhancers (Pongubala et al., 1992;Eisenbeis et al., 1993).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Pongubala et al., 1992
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Eisenbeis et al., 1993 source
- Premisecitation
Pip binding to DNA requires DNA-bound PU.1 phosphorylated at Ser148.
“In each instance, the binding of Pip to DNA is dependent on DNA-bound PU.1, which must be phosphorylated on Ser148 (pSer148; Pongubala et al., 1993).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Pongubala et al., 1993 source
- Interpretationown data
Multiple side chains within Pip amino acids 397-400 may contact PU.1.
“Together, these data suggest that multiple side chains within this region may contact PU.1.”
Quote in the paperSubstantial claim - Premisecitation
The crystal structure of PU.1 DBD bound to DNA shows that the N-terminus of PU.1 faces the binding site for Pip.
“The crystal structure of the PU.1 DBD bound to DNA shows that the N-terminus of PU.1 faces the binding site for Pip (Kodandapani et al., 1996).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kodandapani et al., 1996 source
- Interpretationreasoning
Protein-protein and protein-DNA interactions function coordinately to establish a specific and stable ternary complex.
“These results suggest that protein-protein and protein-DNA interactions function coordinately in establishing a specific and stable ternary complex.”
Quote in the paperSubstantial claim - Interpretationown data
Pip structural determinants important for ternary complex assembly are also required for transcriptional activation in vivo.
“Therefore, the structural determinants of Pip that are important for ternary complex assembly are also required for transcriptional activation in vivo.”
Quote in the paperSubstantial claim - Interpretationown data
The predicted alpha-helix is essential for PU.1-Pip interaction.
“Taken together, these observations suggest that the predicted α-helix is essential for PU.1-Pip interaction.”
Quote in the paperSubstantial claim - Interpretationown data
A functional Pip regulatory domain containing ternary complex and autoinhibition regions resides within an independently folded module (amino acids 170-450).
“Therefore, these experiments establish that a functional regulatory domain, containing the regions necessary for ternary complex formation and autoinhibition, resides within an independently folded protein module (amino acids 170-450).”
Quote in the paperSubstantial claim - Interpretationown data
The Pip DBD's low intrinsic affinity for lambdaB is increased 20- to 40-fold by PU.1.
“Thus, the Pip DBD has a low intrinsic affinity for the λB sequence which is increased 20-to 40-fold by PU.1.”
Quote in the paperSubstantial claim - Interpretationown data
The structural determinants in Pip required for autoinhibition overlap with, but can be uncoupled from, those required for ternary complex formation.
“Interestingly, these experiments showed that the structural determinants in Pip required for autoinhibition of DNA binding overlap with, but can be uncoupled from, those required for ternary complex formation.”
Quote in the paperSubstantial claim - Interpretationown data
This regulatory domain is tethered to the DBD by a protease-sensitive linker.
“This domain is tethered to the DBD by a proteasesensitive linker (Figure 3A, bottom).”
Quote in the paperSubstantial claim - Interpretationreasoning
Partial transcriptional activation by PipAS397 may result from weak association with PU.1 and DNA through an IRF-ets DBD interaction.
“Partial activation of transcription by this mutant protein may be due to its ability to associate weakly with PU.1 and DNA through an interaction between the IRF and ets DBDs (see below).”
Quote in the paperSubstantial claim - Interpretationown data
PU.1 and Pip additionally interact through their DBDs.
“These data suggest that PU.1 and Pip additionally interact through their DBDs.”
Quote in the paperSubstantial claim - Interpretationown data
Any PU.1-induced conformational change within Pip occurs by pivoting of Pip's regulatory domain about the flexible linker.
“These data suggest that any PU.1-induced conformational change within Pip occurs by pivoting of Pip's regulatory domain about the flexible linker.”
Quote in the paperSubstantial claim - Interpretationown data
The PU.1-Pip interaction detected by cross-linking has the same requirements as ternary complex assembly by gel shift.
“Therefore, the PU.1-Pip interaction detected by glutaraldehyde cross-linking displayed the same requirements as those determined for ternary complex assembly using the gel shift assay (Figure 5A and B).”
Quote in the paperSubstantial claim - Interpretationown data
The Kd value is likely an underestimate because at saturation about 75% of recombinant PU.1 interacts with Pip and is phosphorylated appropriately.
“This K d value is likely to be an underestimate, because the binding curve shows that at saturation, ~75% of the recombinant PU.1 interacts with Pip and is therefore phosphorylated appropriately.”
Quote in the paperNot a substantial claim - Interpretationreasoning
A coordinated set of protein-protein and protein-DNA contacts is essential for PU.1-Pip ternary complex assembly.
“Thus, a coordinated set of protein-protein and protein-DNA contacts are essential for PU.1-Pip ternary complex assembly.”
Quote in the paperSubstantial claim - Interpretationown data
Interaction of Pip's regulatory domain with the PEST region of PU.1 greatly enhances DNA-binding cooperativity.
“Thus, the interaction of Pip's regulatory domain with the PEST region of PU.1 greatly enhances DNAbinding cooperativity.”
Quote in the paperSubstantial claim - Study design and conductown data
Nuclear extracts from stably transduced lines formed complexes with λB DNA to similar levels for PipPU and mutant chimeras.
“the PipPU and mutant chimeras formed complexes with λB DNA to similar levels”
Quote in the paperSubstantial claim - Premisecitation
J558L cells express a functionally rearranged Vλ1-Jλ1 IgL allele.
“it expresses a functionally rearranged Vλ1-Jλ1 IgL allele”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Oi et al., 1983
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premiseown data
This helix is also required for transcriptional co-activation.
“This helix is also required for transcriptional co-activation.”
Quote in the paperSubstantial claim - Interpretationown data
On some composite elements, fusing the two DBDs can reproduce the affinity of the PU.1-Pip complex.
“thus demonstrating that on certain composite elements, 984 fusion of the two DBDs can recapitulate the affinity of the PU.1-Pip complex.”
Quote in the paperSubstantial claim - Study design and conductown data
Individual J558L clones expressed similar levels of the chimeric proteins, as shown by Western blotting.
“Individual J558L clones that expressed similar levels of the chimeric proteins were identified by Western blotting”
Quote in the paperSubstantial claim - Interpretationown data
PU.1-Pip complexes are functionally important in B cell gene expression.
“When stably expressed, the wild-type fused dimer strongly repressed the expression of a rearranged immunoglobulin λ gene, thereby establishing the functional importance of PU.1-Pip complexes in B cell gene expression.”
Quote in the paperSubstantial claim - Interpretationown data
PipPU's binding stability depended on Arg232 and Arg235 of the PU.1 DBD.
“suggests that PipPU's binding stability depended on Arg232 and Arg235 of the PU.1 DBD.”
Quote in the paperSubstantial claim - Interpretationown data
The PipPU fused dimer and its variants can distinguish genes regulated by PU.1 and Pip from those regulated by PU.1 alone.
“the overall analysis establishes the utility of using the PipPU fused dimer and its variants to distinguish genes regulated by PU.1 and Pip from those regulated by PU.1 alone.”
Quote in the paperSubstantial claim - Interpretationown data
PU.1 alone is required for J chain gene activity.
“these data demonstrate that PU.1 alone is required for J chain gene activity.”
Quote in the paperSubstantial claim - Interpretationreasoning
Similar residues in ICSBP and p48 may play a general role in IRF-containing complexes, including IRF-3.
“Therefore, such residues may play a more general role in IRF-containing complexes, including those involving IRF-3”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Au et al., 1995
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Wathelet et al., 1998 source
- Study design and conductown data
Comparable levels of all four chimeric proteins were expressed in transfected cells, as determined by Western blotting.
“Comparable levels of all four chimeric proteins were expressed in transfected cells as determined by Western blotting”
Quote in the paperSubstantial claim - Interpretationreasoning
The higher DNA-binding affinity of the ternary complex compared with PU.1 is due to a faster association rate.
“suggesting that the elevated DNA-binding affinity of the ternary complex, as compared with PU.1, is due to an increased rate of association.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The ternary complex may also be stabilized by hydrophobic and/or polar contacts between Pip's Leu400, Ile401, Thr402 and His403 and PU.1.
“The ternary complex may also be stabilized by hydrophobic and/or polar contacts between Pip's Leu400, Ile401, Thr402 and His403, and PU.1.”
Quote in the paperNot a substantial claim - Interpretationown data
Fusing the Pip and PU.1 DBDs produced a protein that bound DNA more stably than wild-type PU.1 or its DBD.
“These results demonstrate that fusion of the Pip and PU.1 DBDs created a protein which bound DNA with much greater stability than wildtype PU.1 or its DBD.”
Quote in the paperSubstantial claim - Study design and conductown data
The chimeric proteins were expressed at considerably higher levels than endogenous PU.1.
“the chimeric proteins were expressed at considerably higher levels than endogenous PU.1”
Quote in the paperNot a substantial claim - Interpretationreasoning
PU.1-Pip association may involve an interaction between PU.1's pSer148 and Pip's Arg398 and Lys399.
“our data suggest a possible mechanism for PU.1-Pip association involving an interaction between PU.1's pSer148 and Pip's Arg398 and Lys399.”
Quote in the paperSubstantial claim - Interpretationown data
Repression of the endogenous IgL λ gene depended on both the PU.1 and Pip DBDs.
“This repression was dependent on both the PU.1 and Pip DBDs”
Quote in the paperSubstantial claim - Interpretationown data
PU.1-Pip complexes are essential for expression of a productively rearranged immunoglobulin λ gene in a plasma cell.
“These results establish that PU.1-Pip complexes are essential for the expression of a productively rearranged immunoglobulin λ gene in a plasma cell.”
Quote in the paperSubstantial claim - Interpretationown data
On the λB site, covalent fusion did not fully reproduce wild-type binding affinity.
“illustrating that on this site the covalent linkage did not fully recapitulate wild-type affinity”
Quote in the paperSubstantial claim - Study design and conductown data
Expression of the fusion proteins did not alter endogenous PU.1 levels.
“determine that expression of the fusion proteins had not altered endogenous PU.1 levels”
Quote in the paperSubstantial claim - Interpretationown data
Cooperative binding of Pip and PU.1 largely depends on interaction between the phosphorylated PEST region of PU.1 and Pip's regulatory domain.
“The cooperative binding of Pip and PU.1 is largely dependent on the interaction between the phosphorylated PEST region of PU.1 and the regulatory domain of Pip”
Quote in the paperSubstantial claim - Interpretationown data
A mutation in Pip's regulatory domain should not perturb the structure of its DBD.
“Thus, a mutation in Pip's regulatory domain should not perturb the structure of its DBD.”
Quote in the paperSubstantial claim - Interpretationreasoning
The enhanced stability is most likely due to increased protein-DNA contacts elevating the free energy of interaction.
“most likely due to the increased protein-DNA contacts elevating the free energy of interaction.”
Quote in the paperSubstantial claim - Interpretationown data
Upon interaction with PU.1 and DNA, Pip undergoes a conformational change that moves its regulatory domain away from its DBD and into contact with PU.1's PEST region.
“Upon interaction of Pip with PU.1 and DNA, Pip undergoes a conformational change involving the swiveling of its regulatory domain (amino acids 170-450) away from its own DBD, and into direct contact with PU.1's PEST region.”
Quote in the paperSubstantial claim - Interpretationown data
Pip's regulatory domain autoinhibits DNA binding by masking the DBD via direct hydrophobic contacts.
“(i) Pip's regulatory domain autoinhibits DNA binding by masking the DBD via direct hydrophobic contacts.”
Quote in the paperSubstantial claim - Interpretationreasoning
Dependence of this IRF subgroup on a DNA-binding partner creates additional specificity in gene regulation.
“The dependence of this subgroup on a DNAbinding partner creates additional specificity in gene regulation, thereby expanding the utility of the IRF DBD.”
Quote in the paperSubstantial claim - Interpretationown data
PipAS397's binding properties are unlikely to result from misfolding because Pip consists of two independent structural domains separated by a flexible linker.
“It is unlikely that the binding properties of PipAS397 are the result of misfolding of this polypeptide, because our proteolytic analysis shows that Pip is composed of two independent structural domains, a DBD domain and a regulatory domain, separated by a flexible linker.”
Quote in the paperSubstantial claim - Interpretationcitation
In both instances, transcription-activating complexes form only upon interaction of appropriate partners and cognate DNA, ensuring specific gene regulation.
“In both of these instances, transcription-activating complexes form only upon interaction of the appropriate partners and cognate DNA, thus ensuring the specific regulation of a distinct set of genes.”
Quote in the paperSubstantial claim - Interpretationcitation
Independent binding of PUmut may arise from phosphate backbone contacts from PU.1's DBD stabilizing the weak DNA-binding activity of the Pip DBD.
“The independent binding of PUmut may arise from phosphate backbone contacts provided by PU.1's DBD, which stabilize the weak DNAbinding activity of the Pip DBD.”
Quote in the paperNot a substantial claim - Interpretationcitation
The biological function of autoinhibition is to prevent Pip and ICSBP from binding inappropriately to IFN-regulated promoters and enhancers.
“we propose that the biological function of autoinhibition is to prevent Pip and ICSBP from binding inappropriately to IFN-regulated promoters and enhancers.”
Quote in the paperSubstantial claim - Interpretationown data
The C-terminal region inhibits binding by masking the DBD.
“We propose that this region inhibits binding by masking the DBD”
Quote in the paperSubstantial claim - Interpretationreasoning
Binding interference between PU.1 and IRF-1 results from competition for overlapping sites.
“suggesting that the binding interference between PU.1 and IRF-1 results from the two proteins competing for binding to overlapping sites.”
Quote in the paperSubstantial claim - Interpretationreasoning
In the wild-type ternary complex, both PU.1's DBD N-terminus and PEST region would be positioned to contact Pip.
“It follows then that in the wild-type ternary complex, both the N-terminus of PU.1's DBD (amino acids 160-272) and its PEST region (amino acids 119-159) would be in position to contact Pip.”
Quote in the paperSubstantial claim - Interpretationreasoning
The model provides general insight into concerted action of Ets-IRF complexes in lymphoid and myeloid lineages.
“we believe this model provides general insight into the concerted action of these transcription factors in both lymphoid and myeloid lineages.”
Quote in the paperSubstantial claim - Interpretationown data
The inability of our cross-linking assays to detect interaction is consistent with template DNA stabilizing weak PU.1-Pip protein-protein contacts.
“The inability of our cross-linking assays to detect such an interaction is consistent with template DNA stabilizing weak protein-protein contacts between PU.1 and Pip.”
Quote in the paperSubstantial claim - Premisecitation
Cross-linking experiments showed NFAT-AP-1 adducts detectable only with specific DNA, arguing protein-protein interactions alone are insufficient.
“cross-linking experiments have shown that NFAT-AP-1 adducts are detectable only in the presence of specific DNA, arguing that protein-protein interactions alone are of insufficient strength for productive complexation”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Chen et al., 1995 source
- Interpretationnone given
Autoinhibition is alleviated upon interaction with a specific partner, PU.1 or Spi-B, in the context of a composite regulatory element.
“This autoinhibition is alleviated upon interaction with a specific partner, i.e.PU.1 or Spi-B, in the context of a composite regulatory element.”
Quote in the paperSubstantial claim - Interpretationreasoning
The DBD-DBD interaction is likely an important component of ternary complex formation.
“it is likely that the interaction between the DBDs will be found to be an important component of ternary complex formation.”
Quote in the paperSubstantial claim - Premisecitation
In the PU.1 DBD-DNA co-crystal structure, the N-terminus of PU.1 is adjacent to the predicted Pip binding site.
“in the PU.1 DBD-DNA co-crystal structure, the N-terminus of PU.1 is adjacent to the predicted binding site of Pip.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kodandapani et al., 1996 source
- Premisecitation
The IRF-1-DNA co-crystal structure shows IRF-1 makes extensive contacts with DNA backbone phosphates up to six nucleotides upstream of the GAAA core.
“The recent IRF-1-DNA co-crystal structure (Escalante et al., 1998) reveals that in addition to the specific base contacts made by the recognition helix, IRF-1 makes extensive contacts with DNA backbone phosphates, even as far as six nucleotides upstream of the GAAA recognition core.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Escalante et al., 1998 source
- Interpretationown data
Additional conformational changes needed for cooperativity may occur in the native complex but not in PipPU.
“These results suggest that additional conformational changes necessary for cooperativity may occur in the context of the native complex that are not recapitulated within PipPU.”
Quote in the paperSubstantial claim - Interpretationreasoning
Partial loss of IRF-1-DNA contacts may account for attenuated binding of Pip, ICSBP and p48.
“then partial loss of these interactions may account for the attenuated binding of Pip, ICSBP and p48.”
Quote in the paperSubstantial claim - Interpretationown data
The POU domain linker may be generally resistant to proteolysis in vivo.
“suggesting that this linker may be generally resistant to proteolysis in vivo.”
Quote in the paperSubstantial claim - Premisecitation
The PU.1-DNA co-crystal structure shows numerous protein-DNA backbone contacts.
“This last suggestion is supported by the numerous protein-DNA backbone contacts observed in the PU.1-DNA co-crystal structure”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kodandapani et al., 1996 source
- Interpretationcitation
The selectivity of a chimeric transcription factor depends on intermediate affinity and high specificity of isolated subdomains.
“This is consistent with the overall selectivity of a chimeric transcription factor depending on the intermediate affinity and high specificity of the isolated sub-domains”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Pomerantz et al., 1995 source
- Interpretationown data
PU.1-Pip complexes are essential for IgL λ expression in vivo.
“demonstrating that PU.1-Pip complexes are essential for IgL λ expression in vivo.”
Quote in the paperSubstantial claim - Interpretationreasoning
Additional contacts between the DNA-binding domains of Pip and PU.1 stabilize the ternary complex.
“Additional contacts between Pip's DBD and PU.1's DBD stabilize the ternary complex.”
Quote in the paperSubstantial claim - Interpretationreasoning
Differential DNA-binding properties of the chimeric proteins likely account for their varying abilities to repress endogenous IgL λ transcription.
“Thus, it is likely that the differential DNA-binding properties of the chimeric proteins account for their varying abilities to repress endogenous IgL λ gene transcription.”
Quote in the paperSubstantial claim - Premisenone given
Transcription of rearranged IgL λ gene appears regulated by two enhancers Eλ2-4 and Eλ3-1, which share high sequence identity.
“Transcription of a rearranged IgL λ gene appears to be regulated by two enhancers, E λ2-4 and E λ3-1 , which share high sequence identity.”
Quote in the paperSubstantial claim - Interpretationreasoning
Unlike IgL λ, PU.1 alone is required for J chain gene activity.
“unlike the case with the IgL λ gene, PU.1 alone is required for J chain gene activity.”
Quote in the paperSubstantial claim - Interpretationreasoning
The study establishes a functional requirement for PU.1-Pip complexes for expression of the IgL λ locus in a plasma cell.
“Our study establishes the functional requirement for PU.1-Pip complexes for expression of the IgL λ locus in a plasma cell.”
Quote in the paperSubstantial claim - Interpretationnone given
Pip's regulatory domain, spanning amino acids 170-450, autoinhibits DNA binding by masking the Pip DNA-binding domain.
“Pip's regulatory domain (RD, amino acids 170-450) autoinhibits DNA binding by masking the Pip DBD.”
Quote in the paperSubstantial claim - Interpretationown data
When Pip interacts with a PU.1-DNA template complex, its regulatory domain swivels around the flexible linker and contacts the PEST region of PU.1.
“Interaction of Pip with a PU.1-DNA template complex causes the regulatory domain to swivel about the flexible linker region (L) and contact PU.1's PEST region.”
Quote in the paperSubstantial claim - Interpretationown data
Combined analysis of wild-type dimer with mutants allowed distinguishing genes regulated by PU.1 and Pip from those regulated by PU.1 alone.
“the combined analysis of the wildtype dimer with a series of mutants allowed us to distinguish genes regulated by PU.1 and Pip from those regulated by PU.1 alone.”
Quote in the paperSubstantial claim - Premisecitation
Eλ2-4 and Eλ3-1 contain juxtaposed binding sites occupied by multiple factors.
“E λ2-4 and E λ3-1 also contain juxtaposed binding sites occupied by multiple factors”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Rudin and Storb, 1992
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
Stable binding of both DBDs may be necessary for PipPU to compete with endogenous Ets and IRF proteins for site occupancy.
“the stable binding of both its DBDs may be necessary to compete with endogenous Ets and IRF proteins for site occupancy.”
Quote in the paperSubstantial claim - Study design and conductown data
Gel shift analyses confirmed purified proteins had similar specific activities to their mammalian counterparts.
“Gel shift analyses of these purified proteins confirmed that they possesed similar specific activities to their mammalian counterparts.”
Quote in the paperNot a substantial claim - Interpretationreasoning
In stably transduced cells, PipPU's enhanced DNA-binding properties may allow it to locate endogenous EICEs more effectively.
“PipPU's enhanced DNA-binding properties may allow it to locate more effectively a small number of endogenous EICEs”
Quote in the paperSubstantial claim - Interpretationown data
The kinetic stability of fused dimer-DNA complexes correlates with their ability to repress transcription in vivo.
“Thus the kinetic stability of the fused dimer-DNA complexes correlates with their ability to repress transcription in vivo”
Quote in the paperSubstantial claim - Interpretationreasoning
PipPU probably represses IgL λ transcription by disrupting both λ enhancers via displacement of PU.1-Pip complexes.
“The PipPU fused dimer probably represses IgL λ gene transcription by disrupting the function of both λ enhancers via the displacement of PU.1-Pip complexes.”
Quote in the paperSubstantial claim
- May combine two claims. 42
- Classified as probably not a substantial claim. 24
May combine two claims.
PremisecitationPip's regulatory domain contains structural determinants for both PU.1 interaction and autoinhibition.
“Therefore, this domain contains structural determinants important for both PU.1 interaction and autoinhibition (Brass et al., 1996).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Brass et al., 1996 source
May combine two claims.
FindingcitationPip deletion mutants 1-439 and 1-419 retained ternary complex formation with PU.1 and stimulated transcription comparably to full-length Pip.
“Pip deletion mutants which retained the ability to form a ternary complex with PU.1 (1-439 and 1-419; Brass et al., 1996; data not shown) stimulated transcription comparable with full-length Pip.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Brass et al., 1996 source
In the section on Pip amino acids 410–439 (page not supplied), Brass et al. report that deleting Pip to residue 439 did not affect ternary complex formation with PU.1. Our copy does not report the 1–419 mutant or show that these two mutants stimulated transcription comparably to full-length Pip; the citing sentence labels the transcription result “data not shown.” (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationThe POU domain linker flexibly connects the POU homeo- and POU-specific domains and appears unstructured in the Oct-1-DNA co-crystal structure.
“This linker was chosen because it flexibly connects the POU homeo-and POUspecific domains (Herr and Cleary, 1995), and appears unstructured in the Oct-1-DNA co-crystal structure (Klemm et al., 1994).”
Quote in the paperSubstantial claim1 of 2 sources checkedMay combine two claims.
FindingcitationFull-length Pip cannot bind DNA without PU.1, whereas the C-terminal deletion mutant Pip 1-410 can bind DNA independently.
“As shown previously, full-length Pip cannot bind to DNA in the absence of PU.1; however, a C-terminal deletion mutant, Pip 1-410, can bind DNA independently (Figure 2A, compare lanes 2 and 3; Brass et al.,1996).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Brass et al., 1996 source
The deletion-analysis section reports that full-length Pip did not bind DNA independently in its gel-shift assay, while Pip 1–410 did. But the ‘Pip functions as a dichotomous regulator’ section says full-length Pip could bind DNA without PU.1 in cell extracts under different conditions, so the unqualified ‘cannot’ overstates the result. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationJ558L cells express the J chain gene, whose transcription has been suggested to be regulated by PU.1 binding to the J chain promoter.
“J558L B cells also express the J chain gene, the transcription of which has been suggested to be regulated by PU.1 binding to the J chain promoter”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Shin and Koshland, 1993 source
The Discussion (page unavailable) reports that PU.1 binds a regulatory element in the J-chain promoter and activates J-chain transcription. The paper identifies S194 as a J-chain-expressing cell line, but the passages found do not establish that J558L cells express the gene; the cell-line-specific part of the claim is unsupported. (LLM, conf=0.84)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationA predicted α-helix in Pip's C-terminus (aa 395-413) is critical for ternary complex formation and autoinhibition of DNA binding.
“we identified a predicted α-helix within Pip's C-terminus (amino acids 395-413) that is critical for both formation of a ternary complex and autoinhibition of DNA binding”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Brass et al., 1996 source
The Structural basis section postulates that a putative α-helical region may play a key role in ternary complex formation and autoinhibition; the Model section identifies that region as amino acids 399–413, not 395–413. The paper’s deletion results establish the importance of a broader segment, amino acids 410–439, but do not establish that the predicted helix itself is critical. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationProbes B1 and C1 differ in their flanking sequences.
“Probes B1 and C1 differ in their flanking sequences”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites Brass et al., 1996 source
The Gel mobility shift assays section describes a murine κB-site probe, and the Pip is NF-EM5 section describes complexes formed on that probe, but neither identifies probes B1 and C1 or compares their flanking sequences. Searches for “B1 and C1,” “C1 probe,” and “flanking sequences” found no passage addressing the claimed difference. (LLM, conf=0.75)
Experimental — accuracy not yet measured - cites Himmelman et al., 1997
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIRF-3 has a C-terminal autoinhibitory region, and regulated phosphorylation upon viral infection stimulates DNA binding.
“IRF-3 possesses a C-terminal autoinhibitory region.Regulated phosphorylation of this region upon viral infection stimulates DNA binding”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites Lin et al., 1998 source
The Discussion proposes a C-terminal autoinhibitory domain and a model in which virus-induced phosphorylation relieves autoinhibition and leads to DNA binding; the Abstract also reports stimulated DNA binding. The claim states the proposed domain as established and implies that the autoinhibitory domain itself is phosphorylated. The Discussion places that domain at amino acids 407–427, but the phosphorylation sites at 396–405. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites Yoneyama et al., 1998 source
The Discussion reports that viral stimulation induces IRF-3 phosphorylation and sequence-specific DNA-binding activity; the Functional domains of IRF-3 section implicates C-terminal serines 385 and 386 in the virus-induced response. Our copy does not identify a C-terminal autoinhibitory region, and the Discussion says the order of phosphorylation and DNA-binding activation could not be determined. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA recent study suggests PU.1 and Pip can interact in the absence of template DNA.
“A recent study using protein-protein interaction assays suggests that PU.1 and Pip can interact in the absence of template DNA”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Perkel et al., 1998 source
Classified as probably not a substantial claim.
PremisecitationPU.1 nucleates a multi-transcription factor complex on Eκ3'.
“recent work has shown that PU.1 nucleates a multi-transcription factor complex on the E κ3Ј”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Pongubala and Atchison, 1997 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe PU.1- and Pip-binding sites in the λB composite element were identified by methylation interference analysis.
“The PU.1-and Pip-binding sites have been underlined based on methylation interference analysis of the λB site(Eisenbeis et al., 1995).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Eisenbeis et al., 1995 source
May combine two claims.
Findingown dataAlanine substitution of amino acids 401-404 and 405-408 increased DNA binding 9- and 15-fold above background, respectively.
“Alanine substitution of amino acids 401-404 and 405-408 resulted in 9-and 15-fold increases in binding above background, respectively.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFurther deletion into the putative alpha-helix (1-410) severely reduced ternary complex formation and abolished synergistic transcription activation.
“Further deletion into the region encompassing the putative α-helix (1-410) severely reduced ternary complex formation and abolished synergistic activation of transcription.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPipAS397 is defective in PU.1 interaction but remains autoinhibited.
“This mutant protein, PipAS397, is defective in its interaction with PU.1, but is autoinhibited.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe Pip mutant had reduced affinity for composite sites and its binding resembled PU.1.
“the Pip mutant (Pipmut) exhibited reduced affinity for the composite sites, and therefore its binding properties resembled those of PU.1”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe PipPU-DNA complex had a half-life of about 60 min, longer than PU.1 (6 min) or the PU.1 DBD (8 min).
“The estimated half-life for the PipPU-DNA complex (60 min) was considerably longer than that for PU.1 (6 min) or the PU.1 DBD (8 min).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe Pipmut-DNA complex half-life was 60 min, while the PUmut-DNA complex half-life was 6 min.
“the significantly longer half-life of the Pipmut-DNA complex (60 min) as compared with that of the PUmut-DNA complex (6 min)”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPipPU did not inhibit a reporter with a Vκ promoter and intron κ enhancer, indicating specificity.
“transcriptional repression by PipPU was specific, since it did not inhibit the activity of a reporter construct containing a Vκ promoter and the intron κ enhancer”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataEnhancer activity was strongly inhibited by PipPU, Pipmut and PUmut, but not by the DM fused dimer.
“Enhancer activity was strongly inhibited by expression of the PipPU, Pipmut and PUmut, but not by the DM fused dimer”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPipAS397 is defective in interaction with PU.1 but remains autoinhibited.
“The mutant protein, PipAS397, is defective in its interaction with PU.1, but is autoinhibited.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPipmut bound DNA with specificity similar to PU.1 but with a longer half-life.
“resulted in the Pipmut protein, which bound DNA with similar specificity to PU.1, but with a longer half-life.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPUmut independently bound DNA with high affinity and acted differently from Pip.
“the PUmut protein, which contains mutations within the PU.1 DBD, independently bound DNA with high affinity and thus acted quite differently from Pip.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPip, ICSBP and p48 have considerably lower DNA affinity and rely on partners to form high-affinity complexes.
“Pip, ICSBP and p48 possess considerably lower DNA affinity, relying on partners to form high affinity complexes.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPipPU bound the λB site less well than wild-type proteins, but on a lower-affinity composite element it bound equivalently to PU.1-Pip.
“The PipPU chimera bound the λB site less well than the wild-type proteins; however, on a composite element containing a lower affinity PU.1 site, the chimera and PU.1-Pip bound equivalently.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPipPU preferred a composite site over a PU.1 site by 3-fold (λB) or 8-fold (CD20), correlating with wild-type PU.1 affinity.
“Our strategy produced a chimera, PipPU, which preferred a composite site to a PU.1 site by a factor of 3 (λB) or 8 (CD20), correlating with the affinity of wild-type PU.1 for these sites.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPip is composed of two major structural domains, a DNA-binding domain and a regulatory domain, with a linker separating them.
“Pip contains two major structural domains, a DNA-binding domain and a regulatory domain, separated by a linker.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAll three chimeras repressed a λ enhancer-containing reporter in transient assays, with PipPU somewhat more effective.
“all three PipPU chimeras (PipPU, Pipmut and PUmut) repressed transcription of a λ enhancercontaining reporter in transient assays, with PipPU being somewhat more effective than the mutant chimeras.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataA chimeric protein formed by fusing the DNA-binding domains of Pip and PU.1 binds composite elements preferentially and with greater stability.
“Fusing the DBDs of Pip and PU.1 generates a chimeric protein which preferentially binds composite elements with increased stability.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Premisenone givenThe role of PU.1-Pip complexes in regulating endogenous IgL genes remains unresolved.
“However, the role of PU.1-Pip complexes in regulating the expression of endogenous IgL genes remains to be elucidated.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationIn eukaryotes, gene expression is regulated by combinations of transcription factors binding at promoters and enhancers.
“In eukaryotes, gene expression appears to be regulated by the assembly of distinct combinations of transcription factors at promoters and enhancers.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Carey, 1998 source
May combine two claims.
Interpretationown dataOverall helix integrity is necessary for both autoinhibition and ternary complex formation.
“Mutation of E406 to proline also generated a protein which bound DNA independently (32-fold above background), suggesting that overall helix integrity is necessary for both autoinhibition and ternary complex formation (Figure 2A, compare lanes 2 and 12).”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe DBDs of IRF-1 and Pip have structurally diverged such that Pip binds cooperatively with PU.1 while IRF-1 displaces PU.1 from the composite element.
“Therefore, the DBDs of IRF-1 and Pip have structurally diverged, such that Pip binds cooperatively with PU.1, while IRF-1 displaces PU.1 from the composite element.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe alpha-helical region in Pip's C-terminus is important for both PU.1 interaction in vitro and transcriptional synergy in vivo.
“Thus, the α-helical region in Pip's C-terminus is important for both interaction with PU.1 in vitro and transcriptional synergy in vivo.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe Eλ2-4 construct (OPC20) is preferentially active in B cells, and mutations in either the PU.1- or Pip-binding site abolish enhancer function.
“Previous work has shown that the E λ2-4 construct (OPC 20) is preferentially active in B cells, and mutations in either the PU.1-or Pip-binding site within this construct abolish enhancer function”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Eisenbeis et al., 1993 source
May combine two claims.
InterpretationreasoningIn transient assays, wild-type and mutant chimeras effectively blocked enhancer function, likely by displacing endogenous PU.1-Pip complexes.
“Therefore, in transient assays, both the wild-type (PipPU) and mutant chimeras (Pipmut and PUmut) effectively blocked enhancer function, presumably by displacement of endogenous PU.1-Pip complexes.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataEach chimeric protein was expressed comparably with endogenous Pip, and its expression did not alter wild-type Pip levels.
“Each of the chimeric proteins was expressed comparably with endogenous Pip and their expression did not alter wild-type Pip levels”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataβ-actin transcripts were used as a specificity control and for normalization.
“β-actin transcripts were used both as a specificity control and for normalization.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe pKID-KIX interaction is mediated by a phosphoserine in pKID.
“An interaction analogous to the one between PU.1 and Pip, involving the pKID domain of the CREB transcription factor and the KIX domain of the co-activator CBP, is mediated by a phosphoserine residue located within pKID”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Parker et al., 1996 source
May combine two claims.
Premiseown dataPip 1-410 fails to form a ternary complex with PU.1 and fails to activate transcription synergistically with PU.1.
“A Pip deletion mutant, Pip 1-410, which does not form a ternary complex with PU.1 fails to activate transcription synergistically with PU.1.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA single hydrogen bond between the phosphoserine and a tyrosine in CBP is critical for complexation.
“a single hydrogen bond between this phosphoserine and a tyrosine residue within CBP is critical for complexation”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Radhakrishnan et al., 1997 source
May combine two claims.
Interpretationown dataProtein-protein contacts also occur between Pip's DBD and PU.1's DBD and may add specificity and stability to the ternary complex.
“Protein-protein contacts also occur between Pip's DBD and PU.1's DBD and may contribute additional specificity and stability to the ternary complex.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
InterpretationreasoningA binding partner such as PU.1 or STATs may provide lost contacts to Pip or p48 in trans.
“a binding partner, such as PU.1 or STATs, may provide these lost contacts to Pip or p48 in trans, via protein-protein interactions.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningPU.1-Pip ternary complex assembly is regulated by two template-directed protein-protein contacts: one between PU.1's PEST region and Pip's regulatory domain, and one between their DBDs.
“we propose that PU.1-Pip ternary complex assembly is regulated by two template-directed proteinprotein contacts, one between PU.1's PEST region and Pip's regulatory domain, and the second depending on association of PU.1's DBD with that of Pip.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationICSBP DBD strongly repressed IFN-stimulated gene expression and anti-proliferative effects, while full-length ICSBP had little effect.
“The ICSBP DBD strongly repressed both interferon (IFN)-stimulated gene expression and the anti-proliferative effects of IFN, while the full-length protein had little effect on these activities.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Thornton et al., 1996 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn the NFAT-AP-1-DNA complex, NFAT and AP-1 make contacts necessary and sufficient for complex formation on DNA.
“In the NFAT-AP-1-DNA complex, the Rel homology region of NFAT and the bZip domain of AP-1 make extensive contacts with one another that are both necessary and sufficient for complex formation on DNA”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Chen et al., 1998 source
May combine two claims.
Interpretationown dataThis association depends on multiple residues in Pip's interaction helix, including an electrostatic interaction between Pip's Lys399 and PU.1's pSer148.
“This association is dependent on multiple residues within Pip's interaction helix, including an electrostatic interaction between Pip's Lys399 and PU.1's pSer148.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPrevious studies created chimeric transcription factors recognizing synthetic elements or used phage display to create zinc finger proteins.
“Previous studies have either created chimeric transcription factors which recognize synthetic regulatory elements by fusing domains from biologically unrelated proteins, or used phage display technology to create a zinc finger protein which recognizes a DNA site generated by a chromosomal translocation”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
InterpretationreasoningThe approach can test proposed functions of interacting activators in vivo and enable identification of novel genes regulated by such complexes.
“this approach not only serves to test the proposed functions of interacting activators in vivo, but should also enable the identification of novel genes specifically regulated by such activator complexes.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationPip-deficient animals develop normal numbers of B cells including λ-expressors but cannot undergo activation.
“Pip-deficient animals develop normal numbers of B cells (including λ-expressors) which cannot undergo activation”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mittrucker et al., 1997 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenStructures of all constructs were confirmed by dideoxy sequencing.
“The structures of all constructs were confirmed by dideoxy sequencing.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe gel mobility shift assays used equal molar amounts of PU.1 and the chimeric proteins.
“PU.1 and the chimeric proteins are present in equimolar amounts.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenEach measurement in the gel mobility shift assays is the average of at least three independent experiments.
“Each determination represents the average of at least three independent experiments.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataPurified proteins were >80% pure by densitometric analysis of Coomassie-stained SDS-PAGE gels.
“The proteins were Ͼ80% pure as judged by densitometric analysis of Coomassie Blue-stained 12.5% SDS-PAGE gels.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe fold-activation values in the transient transfection assays are averages of two independent experiments.
“Fold-activation (solid bars) indicates CAT activity normalized to the control expression vector and is the average of two independent experiments.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningThis similarity may be due to higher target DNA to non-specific DNA ratio and increased protein expression in transient assays.
“This may be attributable to the higher ratio of target DNA to non-specific DNA as well as increased levels of protein expression in a transient assay.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe displayed Northern blot data come from three separate experiments that each used distinct RNA preparations.
“These data are representative of three independent experiments each using different RNA preparations.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe CAT activity data in the transient transfection assays are averages of two independent transfections.
“Solid bars indicate average CAT activity (percentage chloramphenicol acetylation) of two independent transfections.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataMultiple residues in Pip's interaction helix mediate this contact, including an electrostatic interaction between Pip K399 and PU.1 pSer148.
“This contact is mediated by multiple residues in Pip's interaction helix, including an electrostatic interaction between K399 of Pip and PU.1's pSer148 (P-S148).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe binding reactions contained equal molar amounts of Pip or PipK399A and PU.1 or PU.1S148A.
“Equimolar amounts of Pip or PipK399A, and PU.1 or PU.1S148A were used in the binding reactions.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationPip is dispensable for IgL λ transcription during B cell development but may be required for enhanced expression during B cell activation and terminal differentiation.
“Thus, Pip is dispensable for IgL λ transcription during B cell development but may be required for the enhanced expression of this locus during B cell activation and terminal differentiation.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe Pip proteins were used in equimolar amounts, as determined by PhosphorImager analysis of SDS-PAGE gels.
“Equimolar amounts of the Pip proteins were used based on PhosphorImager analysis of SDS-PAGE gels.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenAll Pip proteins were present in equimolar amounts in the gel mobility shift assays.
“All Pip proteins are present in equimolar amounts.”
Quote in the paperSubstantial claim
The paper relies on this without support.
PU.1 and Pip act as mutually dependent transcriptional activators in vivo.
“As noted, PU.1 and Pip function as mutually dependent transcriptional activators in vivo.”
The paper relies on this without support.
The λB probe's high-affinity PU.1 site (AAGGAA) could mask some of the DNA-binding gain provided by fusing the Pip DBD.
“The λB probe contains a high affinity PU.1-binding site (AAGGAA), which might mask some of the gain in DNA binding provided by the fusion of the Pip DBD.”
The paper relies on this without support.
The CD20 composite element contains a lower-affinity PU.1-binding site (AAAGAA).
“the composite element from the CD20 promoter, which contains a lower affinity PU.1-binding site (AAAGAA”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the two-step recruitment mechanism for PU.1/Pip ternary complex, PU.1/Pip interaction is DNA template-directed and involves two distinct protein-protein interaction surfaces: (i) the ETS (PU.1) and IRF (Pip) DNA binding domains and (ii) the phosphorylated PEST domain of PU.1 and a putative α helix in Pip.
“A model was proposed for PU.1/Pip ternary complex. In this two-step recruitment mechanism, PU.1/Pip interaction is DNA template-directed and involves two distinct protein–protein interaction surfaces: (i) the ETS (PU.1) and IRF (Pip) DNA binding domains and (ii) the phosphorylated PEST domain of PU.1 and a putative α helix in Pip [118, 119] (Fig. 9).”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [119]
The phosphorylated PEST sequence of SPI1 interacts with an autoinhibitory region of IRF4 to enhance DNA binding by almost three orders of magnitude.
“More dramatically, however, the phosphorylated PEST sequence of SPI1 interacts with an autoinhibitory region of IRF4 to enhance DNA binding by almost three orders of magnitude (154).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [154]
The low affinity of the IRF4 winged helix-turn-helix DNA-binding domain for the lambda B enhancer is increased 20- to 40-fold by SPI1 at this site.
“The low affinity of the winged helix-turn-helix DNA-binding domain of IRF4 for the λB enhancer is increased 20–40-fold by the presence of SPI1 at this site (154, 155).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [154]
The PU.1-ICSBP interaction is dependent on the IAD domain in the C-terminal region, although the DBD is also required.
“the PU.1-ICSBP interaction is dependent on the IAD domain in the C-terminal region, although the DBD is also required for this interaction (5, 38).”
From Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element (2002) · cites this paper as [5]
ICSBP has been known to interact with PU.1, a hematopoietic-cell-specific member of the Ets family.
“ICSBP has been known to interact with PU.1, a hematopoietic-cellspecific member of the Ets family (4, 5, 38).”
From Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element (2002) · cites this paper as [5]
PU.1 requires the PEST domain, which is N-terminal to the Ets domain, for interacting with ICSBP.
“PU.1 requires the PEST domain, which is N-terminal to the Ets domain, for interacting with ICSBP (5).”
From Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element (2002) · cites this paper as [5]
ICSBP associates with PU.1 and stimulates activity of the Ets/IRF composite element (EICE), which contains IRS and is present in immunoglobulin κ and λ, gp91phox, scavenger receptor, TLR-4, and IL-1β genes.
“It also associates with PU.1 and stimulates activity of the Ets/IRF composite element (EICE), which also contains IRS and is present in the immunoglobulin (Ig) k and l , gp91 phox , scavenger receptor, toll-like receptor-4 (TLR-4), and interleukin (IL)-1 b genes. (5,23,26-30)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [26]
Irf8 peaks were enriched for EICE motifs, which are co-bound by PU.1.
“Notably, Irf8 peaks were enriched for EICE motifs, which are co-bound by PU.126.”
From Single-cell analysis of mixed-lineage states leading to a binary cell fate choice (2016) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Two different sequences are given for the λB element
MinorThe two sequences identified as λB differ in length and within the stated element, not just in their terminal bases.
“The λB composite element (AAAGGAAGTGAAACCA) contains a PU.1-binding site at its 5Ј end separated by 2 bp from the Pip-binding site.”
“Comparison of the IRF recognition site (GAGAAGTGAAAGT, IRF-1 core in bold) with the λB EICE (AAGGAGTGAAACC, PU.1 core emboldened)”
Residue 406 is identified as two different amino acids
MinorThe proposed proline substitution describes residue 406 as glutamine, but the mutant name and the subsequent comparison identify it as glutamate (Glu).
“Next, we attempted to disrupt the folding of the interaction helix by substituting a proline for glutamine at position 406 (PipE406P).”
“Importantly, mutation of this Glu406 to an alanine had no effect on ternary complex formation, indicating that the nature of the side chain was not critical (data not shown).”
Cites
Empirical Predictions of Protein Conformation
Chou, P. Y., & Fasman, G. D. (1978) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.47.070178.001343 · Cited by 3,137 · see citing works
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532 · see citing works
Self-citationVirus induction of human IFNβ gene expression requires the assembly of an enhanceosome
Thanos, D., & Maniatis, T. (1995) · Cell · doi:10.1016/0092-8674(95)90136-1 · Cited by 1,014 · see citing works
Lin, R., Heylbroeck, C., Pitha, P. M., & Hiscott, J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2986 · Cited by 915 · cited 1× · see citing works
“Regulated phosphorylation of this region upon viral infection stimulates DNA binding (Lin et al., 1998; Yoneyama et al., 1998).”
BackgroundYoneyama, M., Suhara, W., Fukuhara, Y., Fukuda, M., Nishida, E., & Fujita, T. (1998) · The EMBO Journal · doi:10.1093/emboj/17.4.1087 · Cited by 841 · see citing works
Episomal Vectors Rapidly and Stably Produce High-Titer Recombinant Retrovirus
Kinsella, T. M., & Nolan, G. P. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.12-1405 · Cited by 741 · see citing works
Wathelet, M. G., Lin, C. H., Parekh, B. S., Ronco, L. V., Howley, P. M., & Maniatis, T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80051-9 · Cited by 730 · see citing works
Radhakrishnan, I., Pérez-Alvarado, G. C., Parker, D., Dyson, H. J., Montminy, M. R., & Wright, P. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80463-8 · Cited by 728 · see citing works
Dalton, S., & Treisman, R. (1992) · Cell · doi:10.1016/0092-8674(92)90194-h · Cited by 672 · see citing works
Versatile retroviral vectors for potential use in gene therapy.
Hawley, R. G., Lieu, F. H., Fong, A. Z. C., & Hawley, T. S. (1994) · PubMed · Cited by 652 · see citing works
Holtschke, T., Löhler, J., Kanno, Y., Fehr, T., Giese, N., Rosenbauer, F., Lou, J., Knobeloch, K.-P., Gabriele, L., Waring, J. F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81348-3 · Cited by 644 · see citing works
Requirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function
Mittrücker, H.-W., Matsuyama, T., Grossman, A., Kündig, T. M., Potter, J., Shahinian, A., Wakeham, A., Patterson, B., Ohashi, P. S., & Mak, T. W. (1997) · Science · doi:10.1126/science.275.5299.540 · Cited by 583 · see citing works
The enhanceosome and transcriptional synergy.
Carey, M. (1998) · Cell · doi:10.1016/s0092-8674(00)80893-4 · Cited by 553 · see citing works
Giese, K., Kingsley, C., Kirshner, J. R., & Grosschedl, R. (1995) · Genes & Development · doi:10.1101/gad.9.8.995 · Cited by 541 · see citing works
Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA
Chen, L., Glover, J. N. M., Hogan, P. G., Rao, A., & Harrison, S. C. (1998) · Nature · doi:10.1038/32100 · Cited by 521 · see citing works
Klemm, J. D., Rould, M. A., Aurora, R., Herr, W., & Pabo, C. O. (1994) · Cell · doi:10.1016/0092-8674(94)90231-3 · Cited by 506 · see citing works
Nuclear factor of activated T cells contains Fos and Jun
Jain, J., McCaffrey, P. G., Valge-archer, V. E., & Rao, A. (1992) · Nature · doi:10.1038/356801a0 · Cited by 497 · see citing works
Müller, M. M., Ruppert, S., Schaffner, W., & Matthias, P. (1988) · Nature · doi:10.1038/336544a0 · Cited by 462 · see citing works
Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
Eisenbeis, C. F., Singh, H., & Storb, U. (1995) · Genes & Development · doi:10.1101/gad.9.11.1377 · Cited by 447 · see citing works
Self-citationParker, D., Ferreri, K., Nakajima, T., Lamorte, V. J., Evans, R., Koerber, S. C., Hoeger, C., & Montminy, M. R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.2.694 · Cited by 408 · see citing works
Structure of IRF-1 with bound DNA reveals determinants of interferon regulation
Escalante, C. R., Yie, J., Thanos, D., & Aggarwal, A. K. (1998) · Nature · doi:10.1038/34224 · Cited by 397 · see citing works
Immunoglobulin gene expression in transformed lymphoid cells.
Oi, V. T., Morrison, S. L., Herzenberg, L. A., & Berg, P. R. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.3.825 · Cited by 388 · see citing works
Au, W.-C., Moore, P. A., Lowther, W. J., Juang, Y., & Pitha, P. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11657 · Cited by 388 · see citing works
Herr, W., & Cleary, M. A. (1995) · Genes & Development · doi:10.1101/gad.9.14.1679 · Cited by 388 · see citing works
Driggers, P. H., Ennist, D. L., Gleason, S. L., Mak, W. H., Marks, M. S., Levi, B. Z., Flanagan, J. R., Appella, E., & Ozato, K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3743 · Cited by 356 · see citing works
Pongubala, J. M., Nagulapalli, S., Klemsz, M. J., McKercher, S. R., Maki, R. A., & Atchison, M. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.368 · Cited by 354 · see citing works
Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma
Iida, S., Rao, P. H., Butler, M. P., Corradini, P., Boccadoro, M., Klein, B., CHAGANTI, R. S. K., & Dalla‐Favera, R. (1997) · Nature Genetics · doi:10.1038/ng1097-226 · Cited by 335 · see citing works
A new pattern for helix–turn–helix recognition revealed by the PU.l ETS–domain–DNA complex
Kodandapani, R., Pio, F., Ni, C.-Z., Piccialli, G., Klemsz, M., McKercher, S., Maki, R. A., & Ely, K. R. (1996) · Nature · doi:10.1038/380456a0 · Cited by 315 · see citing works
In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence
Choo, Y., Sánchez-García, I., & Klug, A. (1994) · Nature · doi:10.1038/372642a0 · Cited by 292 · see citing works
Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation
Pongubala, J., Van Beveren, C., Nagulapalli, S., Klemsz, M., McKercher, Maki, R., & Atchison, M. (1993) · Science · doi:10.1126/science.8456286 · Cited by 282 · cited 7× · see citing works
“Formation of the PU.1– Pip protein adduct was dependent on: (i) phosphorylation of Ser148 in PU.1; (ii) Lys399 in Pip’s interaction helix; and (iii) λB DNA containing intact PU.1- and Pip-binding sites (Figure 5B, lanes 3–8, probes designated B1 and B2 contain severe mutations in either the PU.1- or Pip-binding sites;…”
BackgroundInfluentialBrass, A. L., Kehrli, E., Eisenbeis, C. F., Storb, U., & Singh, H. (1996) · Genes & Development · doi:10.1101/gad.10.18.2335 · Cited by 242 · see citing works
Self-citationCrystal structure of the yeast MATα2/MCM1/DNA ternary complex
Tan, S., & Richmond, T. J. (1998) · Nature · doi:10.1038/35563 · Cited by 236 · see citing works
Bender, A., & Sprague, G. F. (1987) · Cell · doi:10.1016/0092-8674(87)90326-6 · Cited by 235 · see citing works
Structure-Based Design of Transcription Factors
Pomerantz, J. L., Sharp, P. A., & Pabo, C. O. (1995) · Science · doi:10.1126/science.7809612 · Cited by 226 · cited 2× · see citing works
“…factors which recognize synthetic regulatory elements by fusing domains from biologically unrelated proteins, or used phage display technology to create a zinc finger protein which recognizes a DNA site generated by a chromosomal translocation (Choo et al., 1994; Pomerantz et al., 1995).”
BackgroundYamagata, T., Nishida, J., Tanaka, T., Sakai, R., Mitani, K., Yoshida, M., Taniguchi, T., Yazaki, Y., & Hirai, H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1283 · Cited by 196 · see citing works
Nelson, N., Marks, M. S., Driggers, P. H., & Ozato, K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.588 · Cited by 192 · see citing works
Nelson, N., Marks, M. S., Driggers, P. H., & Ozato, K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.588-599.1993 · Cited by 192 · cited 1× · see citing works
“ICSBP is a lympho-myeloid-restricted repressor of interferon-inducible gene transcription (Driggers et al., 1990; Nelson et al., 1993).”
BackgroundEisenbeis, C. F., Singh, H., & Storb, U. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6452 · Cited by 182 · see citing works
Self-citationDefective B cell receptor‐mediated responses in mice lacking the Ets protein, Spi‐B
Su, G. H., Chen, H., Muthusamy, N., Garrett‐Sinha, L. A., Baunoch, D., Tenen, D. G., & Simon, M. C. (1997) · The EMBO Journal · doi:10.1093/emboj/16.23.7118 · Cited by 182 · see citing works
Sharf, R., Meraro, D., Azriel, A., Thornton, A. M., Ozato, K., Petricoin, E. F., Larner, A. C., Schaper, F., Hauser, H., & Levi, B.-Z. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.9785 · Cited by 162 · see citing works
Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1.
Ray, D., Bosselut, R., Ghysdael, J., Mattei, M. G., Tavitian, A., & Moreau-Gachelin, F. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.10.4297 · Cited by 157 · see citing works
Veals, S. A., Maria, T. S., & Levy, D. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.196-206.1993 · Cited by 136 · see citing works
Klemm, J. D., & Pabo, C. O. (1996) · Genes & Development · doi:10.1101/gad.10.1.27 · Cited by 134 · see citing works
Shin, M. K., & Koshland, M. E. (1993) · Genes & Development · doi:10.1101/gad.7.10.2006 · Cited by 126 · see citing works
The Ets protein Spi-B is expressed exclusively in B cells and T cells during development.
Su, G. H., Ip, H. S., Cobb, B. S., Lu, M. M., Chen, H. M., & Simon, M. C. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.1.203 · Cited by 113 · see citing works
PU.1 Recruits a Second Nuclear Factor to a Site Important for Immunoglobulin κ 3' Enhancer Activity
Pongubala, J. M. R., Nagulapalli, S., Klemsz, M. J., McKercher, S. R., Maki, R. A., & Atchison, M. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.368-378.1992 · Cited by 105 · see citing works
Hagman, J., Rudin, C. M., Haasch, D., Chaplin, D., & Storb, U. (1990) · Genes & Development · doi:10.1101/gad.4.6.978 · Cited by 100 · see citing works
Sharf, R., Azriel, A., Lejbkowicz, F., Winograd, S. S., Ehrlich, R., & Levi, B.-Z. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13063 · Cited by 100 · see citing works
PU.1 can participate in an active enhancer complex without its transcriptional activation domain
Pongubala, J. M. R., & Atchison, M. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.127 · Cited by 86 · see citing works
Himmelmann, A. W., Riva, A., Wilson, G. L., Lucas, B. P., Thévenin, C., & Kehrl, J. H. (1997) · Blood · doi:10.1182/blood.v90.10.3984 · Cited by 84 · see citing works
Tanaka, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4311 · Cited by 79 · see citing works
A Two-Step Mechanism for Recruitment of Pip by PU.1
Perkel, J. M., & Atchison, M. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.241 · Cited by 77 · see citing works
Veals, S. A., Maria, T. S., & Levy, D. E. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.196 · Cited by 72 · see citing works
Physical linkage of the constant region genes for immunoglobulins lambda I and lambda III.
Miller, J., Bothwell, A. L. M., & Storb, U. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3829 · Cited by 65 · see citing works
Only one of the two DNA-bound orientations of AP-1 found in solution cooperates with NFATp
Chen, L., Oakley, M. G., Mark Glover, J. N., Jain, J., B. Dervan, P., Hogan, P. G., Rao, A., & Verdine, G. L. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00178-3 · Cited by 64 · see citing works
Shah, P. C., Bertolino, E., & Singh, H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.23.7105 · Cited by 61 · see citing works
Self-citationEisenbeis, C. F., Singh, H., & Storb, U. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6452-6461.1993 · Cited by 38 · see citing works
Self-citationCharacterization of Spi-B, a Transcription Factor Related to the Putative Oncoprotein Spi-l/PU.l
Ray-Gallet, D., Bosselut, R., Ghysdael, J., Mattéi, M., Tavitian, A., & Moreau-Gachelin, F. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.10.4297-4304.1992 · Cited by 35 · see citing works
Thornton, A. M., Ogryzko, V. V., Dent, A., Sharf, R., Levi, B. Z., Kanno, Y., Staudt, L. M., Howard, B. H., & Ozato, K. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.11.5145 · Cited by 25 · see citing works
Two Conserved Essential Motifs of the Murine Immunoglobulin λ Enhancers Bind B-Cell-Specific Factors
Rudin, C. M., & Storb, U. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.309-320.1992 · Cited by 25 · see citing works
A new pattern for helix–turn–helix recognition revealed by the PU.1 ETS-domain–DNA complex
Kodandapani, R., Pio, F., Ni, C., Piccialli, G., Klemsz, M. J., McKercher, S. R., Maki, R. A., & Ely, K. R. (1998) · Nature · doi:10.1038/33467 · Cited by 18 · see citing works
Rudin, C. M., & Storb, U. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.309 · Cited by 17 · see citing works
Klemm, J. D., Rould, M. A., Aurora, R., et al. (1994) · Worldwide Protein Data Bank · doi:10.2210/pdb1oct/pdb
YEAST MATALPHA2/MCM1/DNA TERNARY TRANSCRIPTION COMPLEX CRYSTAL STRUCTURE: 1mnm
Tan, S., & Richmond, T. J. (1998) · Worldwide Protein Data Bank · doi:10.2210/pdb1mnm/pdb
Flagged first, then by citations
Research works printed but not linked: 1
- Brass AL (1998) PU.1/Pip ternary complex formation. PhD thesis, University of Chicago, Chicago, IL.
Cited by
Sorted by citations
IRF Family of Transcription Factors as Regulators of Host Defense
Taniguchi, T., Ogasawara, K., Takaoka, A., & Tanaka, N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.623 · Cited by 1,658 · see citing works
The ETS-domain transcription factor family
Sharrocks, A. D. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099076 · Cited by 1,086 · see citing works
Molecular biology of the Ets family of transcription factors
Oikawa, T., & Yamada, T. (2003) · Gene · doi:10.1016/s0378-1119(02)01156-3 · Cited by 684 · see citing works
Sciammas, R., Shaffer, A. L., Schatz, J. H., Zhao, H., Staudt, L. M., & Singh, H. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.009 · Cited by 564 · see citing works
Self-citationInterferon regulatory factors: the next generation
Mamane, Y., Heylbroeck, C., Génin, P., Algarté-Génin, M., Servant, M. J., Page, C. L., DeLuca, C., Kwon, H., Lin, R., & Hiscott, J. B. (1999) · Gene · doi:10.1016/s0378-1119(99)00262-0 · Cited by 570 · see citing works
Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
Yang, Y., Shaffer, A. L., Emre, N. C. T., Ceribelli, M., Zhang, M., Wright, G. W., Xiao, W., Powell, J. I., Platig, J., Kohlhammer, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.024 · Cited by 524 · see citing works
“1 fusion functions as a sequence-specific transcriptional repressor (Brass et al., 1999).”
BackgroundGenomic and biochemical insights into the specificity of ETS transcription factors
Hollenhorst, P. C., McIntosh, L. P., & Graves, B. J. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.79.081507.103945 · Cited by 490 · see citing works
“The low affinity of the winged helix-turn-helix DNA-binding domain of IRF4 for the λB enhancer is increased 20–40-fold by the presence of SPI1 at this site (154, 155).”
Transcriptional Regulation of Germinal Center B and Plasma Cell Fates by Dynamical Control of IRF4
Ochiai, K., Maienschein‐Cline, M., Simonetti, G., Chen, J., Rosenthal, R. L., Brink, R. A., Chong, A. S., Klein, U., Dinner, A. R., Singh, H., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.009 · Cited by 469 · see citing works
“Molecular redundancy between PU.1 and SpiB in the Ets family, as well as between IRF4 and IRF8 in the IRF family, can result in the targeting of the EICE motif by four distinct Ets-IRF ternary complexes (Eisenbeis et al., 1995).”
InfluentialSelf-citationSingle-cell analysis of mixed-lineage states leading to a binary cell fate choice
Olsson, A., Venkatasubramanian, M., Chaudhri, V. K., Aronow, B. J., Salomonis, N., Singh, H., & Grimes, H. L. (2016) · Nature · doi:10.1038/nature19348 · Cited by 476 · see citing works
Self-citationPathogenesis of Human B Cell Lymphomas
Shaffer, A. L., Young, R. M., & Staudt, L. M. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075027 · Cited by 437 · see citing works
Compensatory dendritic cell development mediated by BATF–IRF interactions
Tussiwand, R., Lee, W.-L., Murphy, T. L., Mashayekhi, M., Wumesh, K. C., Albring, J. C., Satpathy, A. T., Rotondo, J. A., Edelson, B. T., Kretzer, N. M., et al. (2012) · Nature · doi:10.1038/nature11531 · Cited by 419 · see citing works
Self-citationSpecificity through cooperation: BATF–IRF interactions control immune-regulatory networks
Murphy, T. L., Tussiwand, R., & MURPHY, K. M. M. (2013) · Nature reviews. Immunology · doi:10.1038/nri3470 · Cited by 399 · see citing works
Saito, M., Gao, J., Basso, K., Kitagawa, Y., Smith, P. M., Bhagat, G., Pernis, A. B., Pasqualucci, L., & Dalla‐Favera, R. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.011 · Cited by 386 · see citing works
Glasmacher, E., Agrawal, S., Chang, A. B., Murphy, T. L., Zeng, W., Vander Lugt, B., Khan, A. A., Ciofani, M., Spooner, C. J., Rutz, S., et al. (2012) · Science · doi:10.1126/science.1228309 · Cited by 361 · see citing works
Self-citationRengarajan, J., Mowen, K. A., McBride, K. D., Smith, E. D., Singh, H., & Glimcher, L. H. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011128 · Cited by 332 · see citing works
“IRF4 constructs have been published previously (19, 20).”
BackgroundSelf-citationHematopoietic cytokines, transcription factors and lineage commitment
Zhu, J., & Emerson, S. G. (2002) · Oncogene · doi:10.1038/sj.onc.1205318 · Cited by 327 · see citing works
“The interferon consensus sequence binding protein (ICSBP/IRF-8), a putative transcriptional partner of PU.1 (Brass et al., 1999), was recently found to be essential for monocytic development while inhibiting the production of neutrophils from GMCSF-dependent ICSBP7/7 cell line Tot2 and granulocytic…”
BackgroundChistiakov, D. A., Myasoedova, V. A., Revin, V. V., Orekhov, A. N., & Bobryshev, Y. V. (2018) · Immunobiology · doi:10.1016/j.imbio.2017.10.005 · Cited by 311 · see citing works
ICSBP Directs Bipotential Myeloid Progenitor Cells to Differentiate into Mature Macrophages
Tamura, T., Nagamura-Inoue, T., Shmeltzer, Z., Kuwata, T., & Ozato, K. (2000) · Immunity · doi:10.1016/s1074-7613(00)00016-9 · Cited by 305 · see citing works
Menezes, S., Melandri, D., Anselmi, G., Perchet, T., Loschko, J., Dubrot, J., Patel, R., Gautier, E. L., Hugues, S., Longhi, M. P., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.12.001 · Cited by 288 · see citing works
“PU.1 can bind to Ets binding sites on its own, but PU.1 also cooperates with IRF4 or IRF8 at Ets-IRF composite response elements called EICEs (Brass et al., 1999).”
IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte developmentPreprint
Lu, R., Medina, K. L., Lancki, D. W., & Singh, H. (2003) · Genes & Development · doi:10.1101/gad.1104803 · Cited by 275 · see citing works
Self-citationDendritic cells in cancer immunology
Murphy, T. L., & MURPHY, K. M. M. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00741-5 · Cited by 272 · see citing works
Sheffield, N. C., Thurman, R. E., Song, L., Safi, A., Stamatoyannopoulos, J. A., Lenhard, B., Crawford, G. E., & Furey, T. S. (2013) · Genome Research · doi:10.1101/gr.152140.112 · Cited by 206 · see citing works
“IRFs may also bind in complex with SPI1, another hematopoietic factor, forming a longer TFBS (Brass et al. 1999).”
BackgroundInfluentialThe genetic network controlling plasma cell differentiation
Nutt, S. L., Taubenheim, N., Hasbold, J., Corcoran, L. M., & Hodgkin, P. D. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.08.010 · Cited by 224 · see citing works
IRF4 at the crossroads of effector T‐cell fate decision
Huber, M., & Lohoff, M. D. (2014) · European Journal of Immunology · doi:10.1002/eji.201344279 · Cited by 221 · see citing works
Expression and function of Ets transcription factors in mammalian development: a regulatory network
Maroulakou, I. G., & Bowe, D. B. (2000) · Oncogene · doi:10.1038/sj.onc.1204039 · Cited by 220 · see citing works
“PU.1 is a potent regulator of proliferation and di erentiation in the hematopoietic system (Figure 1) (Brass et al., 1999).”
BackgroundIRF4: Immunity. Malignancy! Therapy?
Shaffer, A. L., Emre, N. C. T., Romesser, P. B., & Staudt, L. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1845 · Cited by 189 · see citing works
Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells
Tamura, T., & Ozato, K. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452755 · Cited by 183 · see citing works
“(4,24,25) It 26–30) Interactions with IRF-1/2 and PU.1 significantly enhance DNA-binding activity of ICSBP and are mediated through the IAD.”
MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies
Tsuboi, K., Iida, S., Inagaki, H., Kato, M., Hayami, Y., Hanamura, I., Miura, K., Harada, S., Kikuchi, M., Komatsu, H., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401696 · Cited by 177 · see citing works
Muljo, S. A., & Schlissel, M. S. (2002) · Nature Immunology · doi:10.1038/ni870 · Cited by 164 · see citing works
Transcription Factors in Lymphocyte Development— T and B Cells Get Together
Glimcher, L. H., & Singh, H. (1999) · Cell · doi:10.1016/s0092-8674(00)80955-1 · Cited by 161 · see citing works
Self-citationDirect Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease
Antonczyk, A., Krist, B., Sajek, M., Sekrecka, A., Piaszyk-Borychowska, A., Plens-Gałąska, M., Wesoły, J., & Bluyssen, H. A. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01176 · Cited by 156 · see citing works
“1-IRF4 dimer can potently represses the expression of the immunoglobulin lambda gene (the small polypeptide subunit of any antibody), and thus is of critical importance in the regulation of B cell gene expression (108).”
BackgroundCrystal structure of PU. 1/IRF-4/DNA ternary complex
Escalante, C. R., Brass, A. L., Pongubala, J. M. R., Shatova, E., Shen, L., Singh, H., & Aggarwal, A. K. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00703-7 · Cited by 154 · see citing works
Self-citationMeraro, D., Hashmueli, S., Koren, B., Azriel, A., Oumard, A., Kirchhoff, S., Hauser, H., Nagulapalli, S., Atchison, M. L., & Levi, B.-Z. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6468 · Cited by 147 · see citing works
The diverse roles of IRF4 in late germinal center B‐cell differentiation
Silva, N. S. D., Simonetti, G., Heise, N., & Klein, U. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01113.x · Cited by 141 · see citing works
“1 (SPI-1) protein at the k and j enhancer segments of immunoglobulin (Ig) genes, where it is essential for the expression of a productively rearranged immunoglobulin gene (19).”
BackgroundInfluentialMarié, I., Smith, E., Prakash, A., & Levy, D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8803-8814.2000 · Cited by 161 · see citing works
“For instance, IRF9 (ISGF3g) recruits tyrosine-phosphorylated STAT1 and/or STAT2 proteins (3, 41, 47) while IRF4 (Pip) and IRF8 (ICSBP) recruit the Ets protein PU.1 ( 6 , 7). This domain, which has been referred to as the IRF association domain (IAD), is capable of mediating dimer formation among IRF partners as well a…”
BackgroundFalvo, J. V., Parekh, B. S., Lin, C. H., Fraenkel, E., & Maniatis, T. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.13.4814-4825.2000 · Cited by 140 · see citing works
“Phosphorylation-independent interaction between the DNAbinding domains of the two proteins contributes to the stability of the ternary complex, and correct spacing between the IRF and ETS binding sites is critical for complex formation (3, 64).”
BackgroundMethodThe IgH Locus 3′ Regulatory Region
Pinaud, E., Marquet, M., Fiancette, R., Péron, S., Vincent‐Fabert, C., Denizot, Y., & Cogné, M. (2011) · Advances in immunology · doi:10.1016/b978-0-12-387663-8.00002-8 · Cited by 134 · see citing works
“Among interferon-induced factors, IRF4 /Pip synergistically interacts with PU.1 and E47 but this effect is inhibited by Bcl6 in GC and Blimp1 in plasma cells (Brass et al., 1999; Gupta et al., 2001; Nagulapalli and Atchison, 1998).”
BackgroundMonocyte differentiation and macrophage polarization
Orekhov, A. N., Orekhova, V. A., Nikiforov, N. G., Myasoedova, V. A., Grechko, A. V., Romanenko, E. B., Zhang, D., & Chistiakov, D. A. (2019) · Vessel Plus · doi:10.20517/2574-1209.2019.04 · Cited by 137 · see citing works
“Among the pro-inflammatory genes induced by IRF-8 are IL-12p40, IL-12p35, IFN-β, and iNOS, that are characteristic for the M1 macrophage phenotype[55].”
BackgroundInfluentialKuo, T. C., & Calame, K. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5556 · Cited by 132 · see citing works
“87 nM, which is similar to a previously determined Kd for its binding to this site (34).”
BackgroundEssential role of interferon regulatory factor 4 (IRF4) in immune cell development
Nam, S., & Lim, J. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0854-1 · Cited by 124 · see citing works
“factors), an auto-inhibitory domain, and a nuclear-localization signal (Brass et al. 1999) (Fig.”
BackgroundWhen Ets transcription factors meet their partners
Verger, A., & Duterque‐Coquillaud, M. (2002) · BioEssays · doi:10.1002/bies.10068 · Cited by 134 · see citing works
Mudter, J., Amoussina, L., Schenk, M., Yu, J., Brüstle, A., Weigmann, B., Atreya, R. N., Wirtz, S. J., Becker, C., Hoffman, A. W., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33227 · Cited by 130 · see citing works
Chinenov, Y., & Rogatsky, I. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.04.014 · Cited by 133 · see citing works
Immune cell-specific amplification of interferon signaling by the IRF-4/8-PU. 1 complex
Kanno, Y., Levi, B.-Z., Tamura, T., & Ozato, K. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.770 · Cited by 128 · see citing works
“39,40 Cocrystallization of the PU.1 Ets domain and IRF-4 DNA-binding domain bound to the EICE DNA revealed a 3D structure of the complex and important contact residues.”
Fate Decisions Regulating Bone Marrow and Peripheral B Lymphocyte Development
Monroe, J. G., & Dorshkind, K. A. (2007) · Advances in immunology · doi:10.1016/s0065-2776(07)95001-4 · Cited by 121 · see citing works
Ma, S., Pathak, S., Trinh, L. X., & Lu, R. (2007) · Blood · doi:10.1182/blood-2007-08-110106 · Cited by 117 · see citing works
Lehtonen, A., Veckman, V., Nikula, T., Lahesmaa, R., Kinnunen, L., Matikainen, S., & Julkunen, I. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6570 · Cited by 112 · see citing works
Modulation of T Cell Cytokine Production by Interferon Regulatory Factor-4
Hu, C.-M., Jang, S. Y., Fanzo, J., & Pernis, A. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205895200 · Cited by 112 · see citing works
Interferon regulatory factor 4 and 8 in B-cell development
Lu, R. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.07.006 · Cited by 111 · see citing works
“1 or Spi-B and bind to the Ets-IRF composite element (EICE; GGAAnnGAAA) located in immunoglobulin (Ig) light chain κ 3’ (Ek3’) and λ gene enhancer regions [2-4].”
BackgroundMarecki, S., Riendeau, C. J., Liang, M. D., & Fenton, M. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6829 · Cited by 111 · see citing works
“1/IRF-4 synergy, reminiscent of the activity of K399A IRF-4 in macrophages, a finding consistent with previous studies (27).”
InfluentialIRF4 regulates IL-17A promoter activity and controls RORγt-dependent Th17 colitis in vivo
Mudter, J., Yu, J., Zufferey, C., Brüstle, A., Wirtz, S. J., Weigmann, B., Hoffman, A. W., Schenk, M., Galle, P. R., Lehr, H. A., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21476 · Cited by 108 · see citing works
“1.(15) IRF4 is expressed in B cells, mature T cells, dendritic cells, and macrophages, and its expression is up-regulated by IgM or TCR crosslinking as well as costimulation in lymphocytes.”
BackgroundQing, J., Zhang, Y. E., & Derynck, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004731200 · Cited by 110 · see citing works
Posttranslational Regulation of IRF-4 Activity by the Immunophilin FKBP52
Mamane, Y., Sharma, S., Petropoulos, L., Lin, R., & Hiscott, J. B. (2000) · Immunity · doi:10.1016/s1074-7613(00)80166-1 · Cited by 95 · see citing works
IFN Regulatory Factor 4 and 8 Promote Ig Light Chain κ Locus Activation in Pre-B Cell Development
Ma, S., Turetsky, A., Trinh, L. X., & Lu, R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7898 · Cited by 95 · see citing works
NF-IL6 (C/EBPβ) Vigorously Activates il1b Gene Expression via a Spi-1 (PU.1) Protein-Protein Tether
Yang, Z., Wara-aswapati, N., Chen, C., Tsukada, J., & Auron, P. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000145200 · Cited by 92 · see citing works
Martinvalet, D. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0237-7 · Cited by 91 · see citing works
Reactive Oxygen Species: Do They Play a Role in Adaptive Immunity?
Bassoy, E. Y., Walch, M., & Martinvalet, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.755856 · Cited by 90 · see citing works
Transcriptional determinants of tolerogenic and immunogenic states during dendritic cell maturation
Lugt, B. V., Riddell, J., Khan, A. A., Hackney, J. A., Lesch, J., DeVoss, J., Weirauch, M. T., Singh, H., & Mellman, I. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201512012 · Cited by 85 · see citing works
Self-citationMarecki, S., Atchison, M. L., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2713 · Cited by 87 · see citing works
Guria, S., Hoory, A., Das, S., Chattopadhyay, D., & Mukherjee, S. (2023) · Bioscience Reports · doi:10.1042/bsr20220200 · Cited by 98 · see citing works
Banerjee, S., Lu, J. L., Cai, Q., Saha, A., Jha, H. C., Dzeng, R. K., & Robertson, E. S. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003314 · Cited by 81 · see citing works
“So, it was possible that IRF4 interacts with EBNA3C through a Spi-1 or Spi-B motif.”
BackgroundInfluentialTargeting IRF4 in autoimmune diseases
Xu, W., Pan, H., Ye, D., & Xu, Y. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.08.011 · Cited by 80 · see citing works
“IRF4 protein comprises a single polypeptide chain [9] that could be roughly split into three parts: a functional regulatory domain containing two transactivation domains (TAD) and regions required for ternary complex formation and auto-suppression [10], a highly conserved N-terminal DNA-binding domain (DBD), which is…”
BackgroundIRF4 in multiple myeloma—Biology, disease and therapeutic target
Agnarelli, A., Chevassut, T. J. T., & Mancini, E. J. (2018) · Leukemia Research · doi:10.1016/j.leukres.2018.07.025 · Cited by 76 · see citing works
IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis?
Biswas, P. S., Bhagat, G., & Pernis, A. B. (2009) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00864.x · Cited by 81 · see citing works
Little, H., Rorick, N. K., Su, L.-I., Baldock, C., Malhotra, S., Jowitt, T., Gakhar, L., Ramaswamy, S., Schutte, B. C., Dixon, M. J., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn381 · Cited by 80 · see citing works
Gupta, P., Gurudutta, G. U., Saluja, D., & Tripathi, R. P. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00757.x · Cited by 74 · see citing works
“Specifically, the first step involves an interaction between the DNA binding domains of PU.1 and Pip.”
BackgroundInfluentialPU.1/Interferon Regulatory Factor Interactions; Mechanisms of Transcriptional Regulation
Marecki, S., & Fenton, M. J. (2000) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:33:2:127 · Cited by 74 · see citing works
“1 and IRF-4 DBDs, connected by a flexible linker, inhibited Ig λ light chain enhancer expression in B cells, implying in vivo binding of this element (110).”
BackgroundIRF4 haploinsufficiency in a family with Whipple’s disease
Guérin, A., Kerner, G., Marr, N., Markle, J., Fenollar, F., Wong, N., Boughorbel, S., Avery, D. T., Ma, C. S., Bougarn, S., et al. (2018) · eLife · doi:10.7554/elife.32340 · Cited by 73 · see citing works
PU.1 cooperates with IRF4 and IRF8 to suppress pre-B-cell leukemia
Pang, S. H. M., Minnich, M., Gangatirkar, P., Zheng, Z., Ebert, A., Song, G., Dickins, R. A., Corcoran, L. M., Mullighan, C. G., Busslinger, M., et al. (2016) · Leukemia · doi:10.1038/leu.2016.27 · Cited by 69 · see citing works
Kuwata, T., Gongora, C., Kanno, Y., Sakaguchi, K., Tamura, T., Kanno, T., Basrur, V., Martinez, R., Appella, E., Golub, T., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.21.7439-7448.2002 · Cited by 69 · see citing works
Care, M. A., Cocco, M., Laye, J. P., Barnes, N., Huang, Y., Wang, M., Barrans, S., Du, M., Jack, A., Westhead, D. R., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku451 · Cited by 67 · see citing works
Review: The Role of IRF-4 in Transcriptional Regulation
Marecki, S., & Fenton, M. J. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452737 · Cited by 67 · see citing works
“(93) Also, Oritz et al. (94) identified aa 300–314 and 325–335 as the locations of two predicted a -helices that are also involved in PU.1/IRF-4 protein-protein interaction.”
IRF4 and IRF8: Governing the virtues of B Lymphocytes
Shukla, V., & Lu, R.-Q. (2014) · Frontiers in Biology · doi:10.1007/s11515-014-1318-y · Cited by 61 · see citing works
“Early studies identi fi ed IRF4 and IRF8 as transcription factors that bind the 3 ′ κ enhancer and λ enhancer to regulate the rearrangement and expression of immunoglobulin light chain at the pre-B cell stage (Brass et al., 1996; Brass et al., 1999; Ma et al., 2006).”
Carbone, A., Gloghini, A., Cozzi, M. R., Capello, D., Steffan, A., Monini, P., Marco, L. D., & Gaïdano, G. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02329.x · Cited by 67 · see citing works
Gosselin, D., & Glass, C. K. (2014) · Immunological Reviews · doi:10.1111/imr.12213 · Cited by 64 · see citing works
“1 protein may also modulate its activity in certain conditions (100).”
BackgroundIRF8: Mechanism of Action and Health Implications
Moorman, H. R., Reategui-Almonacid, Y., Poschel, D. B., & Liu, K. (2022) · Cells · doi:10.3390/cells11172630 · Cited by 63 · see citing works
Review: The Role of IRF-4 in B and T Cell Activation and Differentiation
Pernis, A. B. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452728 · Cited by 62 · see citing works
“(41) Interestingly, an additional IRF-4 binding site within the k 3 9 enhancer has also been identified.”
Shin, D., Lee, C., & Morse, H. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027384 · Cited by 55 · see citing works
“1 and IRF4 to regulate gene expression through recognition of ISRE and EICE sequence elements [1,49].”
BackgroundO’Reilly, D., Quinn, C. M., El‐Shanawany, T., Gordon, S., & Greaves, D. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212150200 · Cited by 55 · see citing works
Unlu, S., Kumar, A., Waterman, W. R., Tsukada, J., Wang, K. Z. Q., Galson, D. L., & Auron, P. E. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.02.016 · Cited by 55 · see citing works
“This argues that a complex containing, in-part, a Spi-1•IRF association similar to that observed for the IgλL and 3′IgκL light-chain enhancers (Brass et al., 1996;Brass et al., 1999;Escalante et al., 2002;Perkel and Atchison, 1998) is important for activity.”
BackgroundInfluentialBertolino, E., & Singh, H. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00597-x · Cited by 54 · see citing works
Self-citationRieske, P., & Pongubala, J. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007482200 · Cited by 53 · see citing works
Csumita, M., Csermely, A., Horváth, A., Nagy, G., Monori, F., Göczi, L., Orbea, H. A., Reith, W., & Széles, L. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1112 · Cited by 48 · see citing works
“These results do not imply necessarily that IRF3dimers and ISGF3 (STAT1/STAT2/IRF9) bind EICE motif with a high frequency.”
MethodInfluentialTranscriptional Control of Mature B Cell Fates
Wang, H., Morse, H. C., & Bolland, S. M. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.04.011 · Cited by 48 · see citing works
Arguello, M., Sgarbanti, M., Hernandez, E., Mamane, Y., Sharma, S., Servant, M. J., Lin, R., & Hiscott, J. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206270 · Cited by 52 · see citing works
“This site is coordinately regulated by the transcription factors PU.1 and IRF-4, which form a ternary complex and synergistically activate transcription (Brass et al., 1996, 1999).”
BackgroundAnderson, M. K., Sun, X. H., Miracle, A. L., Litman, G. W., & Rothenberg, E. V. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.553 · Cited by 53 · see citing works
Verger, A., Buisine, E., Carrère‐Kremer, S., Wintjens, R. T., Flourens, A., Coll, J., Stéhelin, D., & Duterque‐Coquillaud, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010208200 · Cited by 50 · see citing works
Interferon Regulatory Factor Signalings in Cardiometabolic Diseases
Zhang, X., Zhang, P., & Li, H. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.04898 · Cited by 50 · see citing works
“1 and SPI-1 or with heterodimers of JUN and basic leucine zipper transcription factor, activating transcription factor-like.(13,14) For IRF5, a homodimer or a heterodimer with IRF3 or IRF7 could be formed after activation.”
BackgroundAnalysis of Gene Expression and Ig Transcription in PU.1/Spi-B-Deficient Progenitor B Cell Lines
Schweitzer, B. L., & DeKoter, R. P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.144 · Cited by 51 · see citing works
“1-IFN regulatory factor (IRF)-4 forced dimer lacking activation domains has been shown to silence Ig transcription in a B cell line (56).”
BackgroundPU.1 and ICSBP control constitutive and IFN-γ-regulatedTlr9gene expression in mouse macrophages
Schroder, K., Lichtinger, M., Irvine, K. M., Brion, K., Trieu, A., Ross, I. L., Ravasi, T., Stacey, K. J., Rehli, M., Hume, D. A., et al. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0107036 · Cited by 51 · see citing works
“1 complex to DNA by EMSA analysis using nuclear extracts from untransfected cells; instead, many used in vitro-translated protein [65–68] or nuclear extracts from transfected cells [69].”
MethodMatsumura, I., Kawasaki, A., Tanaka, H., Sonoyama, J., Ezoe, S., Minegishi, N., Nakajima, K., Yamamoto, M., & Kanakura, Y. (2000) · Blood · doi:10.1182/blood.v96.7.2440 · Cited by 53 · see citing works
Suzuki, Y., Yasuike, M., Kondo, H., Aoki, T., & Hırono, I. (2010) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2010.09.010 · Cited by 49 · see citing works
“This IAD contains RKL amino acid residues which are important to construct of the dimer or trimer with other IRFs and molecules in IRF4 and IRF8 in mammal [58].”
BackgroundBathige, S. D. N. K., Whang, I., Umasuthan, N., Lim, B.-S., Park, M.-A., Kim, E., Park, H., & Lee, J. (2012) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2012.07.017 · Cited by 48 · see citing works
Ochiai, K., Kondo, H., Okamura, Y., Shima, H., Kurokochi, Y., Kimura, K., Funayama, R., Nagashima, T., Nakayama, K., Yui, K., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2017010413 · Cited by 47 · see citing works
Laricchia‐Robbio, L., Tamura, T., Karpova, T., Sprague, B. L., McNally, J. G., & Ozato, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504014102 · Cited by 47 · see citing works
Transcriptional Regulation of Mouse μ Opioid Receptor Gene by PU.1
Hwang, C. K., Kim, C. S., Choi, H. S., McKercher, S. R., & Loh, H. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400755200 · Cited by 46 · see citing works
Haro, L. D. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf390 · Cited by 45 · see citing works
Nakashima, Y., & Haneji, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072033 · Cited by 42 · see citing works
Carrascosa, L. C., Klein, M., Kitagawa, Y., Lückel, C., Marini, F., König, A., Guralnik, A., Raifer, H., Hagner-Benes, S., Raedler, D., et al. (2017) · Nature Communications · doi:10.1038/ncomms15366 · Cited by 41 · see citing works
Teng, Y., Takahashi, Y., Yamada, M., Kurosu, T., Koyama, T., Miura, O., & Miki, T. (2007) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2007.05.006 · Cited by 43 · see citing works
“1 complex has been shown to act as a transcriptional regulator for the B-cell specific genes, such as the rearranged lambda lightchain gene (Brass et al., 1999).”
Background
- Authors
- Brass, A. L., Zhu, A. Q., & Singh, H.
- Affiliations
- Howard Hughes Medical Institute (US)
- Corresponding author
- Singh, Harinder
- Venue
- The EMBO Journal
- Published
- 1999-02-15
- Volume
- 18
- Issue
- 4
- Pages
- 977-991
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC1171190
- OpenAlex
- W2121496836
- Semantic Scholar
- a3891c3b25fac116b2b2c86acc2cf094353cc3d7
- Cited by
- 207
- References
- 64
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 9 · 2023: 8 · 2022: 7 · 2021: 10 · 2020: 8 · 2019: 6 · 2018: 7 · 2017: 6 · 2016: 6 · 2015: 5 · 2014: 6 · 2013: 8 · 2012: 8
- FWCI
- 5.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The EMBO Journal (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
- Keywords
- PU.1, IRF4, Pip, ETS transcription factors, transcription factor interaction, B cell gene expression, transcriptional repression, protein-DNA contacts
- MeSH terms
- Interferon Regulatory Factor-4, Proto-Oncogene Protein Spi-1, Amino Acid Sequence, Animals, B-Lymphocytes, DNA-Binding Proteins, Enhancer Elements, Genetic, Gene Expression Regulation, Immunoglobulin lambda-Chains, Molecular Sequence Data
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-07.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-07.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review